[
    {
        "pmid": "40818491",
        "title": "Optimization of the Monoclonal Antibody 3E1 through W32I Mutation Enhances Antiviral Efficacy against Influenza Virus Subtypes H1N1 and H3N2.",
        "abstract": "influenza virus caused global pandemic significant morbidity mortality underscoring need optimize antibody improved antiviral efficacy monoclonal antibody 3E1 effectively neutralizes Group 1 influenza subtypes H1 H5 inhibiting acidinduced conformational change hemagglutinin HA However neutralizing activity relatively weak Group 2 subtype H3 order broaden neutralizing activity wildtype 3E1 3E1WT Group 1 Group 2 viral strains singlepoint mutant 3E1L W32I 3E1H F103I double mutant 3E1HL F103I W32I designed generated study binding affinity microneutralizing activity antiviral mechanism mutant evaluated vitro Notably 3E1L mutant exhibited significantly enhanced antiviral activity H1N1 H3N2 compared 3E1WT inhibiting viral entry release vivo study also indicate 3E1L significantly enhances prophylactic therapeutic efficacy ANewYork612015CDCLV16A H1N1 AHong Kong1720148296 H3N2 Molecular dynamic simulation 3E1LHA complex revealed W32I mutation could reduce steric hindrance tryptophan position 32 complementaritydetermining region L1 loop HA conclusion W32I substitution enhances antiviral activity 3E1WT suggesting optimization 3E1L promising strategy development effective influenza therapy prevention",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40818491/",
        "source_type": "Global"
    },
    {
        "pmid": "40818177",
        "title": "Exploring social influences on healthcare user decision-making.",
        "abstract": "Commonly used choice model healthcare assume decisionmaking individualistic process individual group ie influencers fact impact decisionmaking purpose study examine different way influencers affect healthcare user decisionmaking important step towards improving choice model healthcare Two focus group n  12 41 semistructured interview conducted within range healthcare domains influenza vaccination birth care joint replacement prostate cancer treatment domains healthcare user physician interviewed Participants recruited collaboration GP hospital research panel Data analyzed grounded theory approach Results reveal three main element decisionmaking affected different social influence mechanisms informationgathering phase perception alternatives attribute level risk influenced information retrieved someone social network others experiences social norms preference formation phase relative importance attribute value alternative impacted social norms advice consideration influencers stake decision Finally process actual decisionmaking could deliberationbased intuitionbased discussion consultation others exact strength impact influence differed per healthcare domain study provides insight social influence healthcare user decisionmaking across multiple healthcare domain provides comparison domains Several connection influencers social influence mechanism choice construct identified finding help choice modeler develop model accurately reflect decisionmaking process health",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40818177/",
        "source_type": "Global"
    },
    {
        "pmid": "40818041",
        "title": "Double Trouble: A Case of ARDS as a Consequence of Influenza and Plasma Donation Causing Severe Neutropenia and Hypogammaglobulinemia.",
        "abstract": "Influenza infection known induce significant immunosuppression particularly vulnerable populations impact exacerbated underlying immunodeficiencies case report describes rapid deterioration previously healthy 30yearold male developed acute respiratory distress syndrome septic shock due methicillinresistant iStaphylococcus aureusi pneumonia bacteremia following Influenza infection patient history frequent plasma donations leading significant reduction immunoglobulin contributing increased susceptibility bacterial coinfection patients condition declined rapidly necessitating venovenous extracorporeal membrane oxygenation ECMO venoarterialvenous ECMO However despite treatment interventions continued deteriorate sustaining cardiac arrest death case highlight potential risk associated frequent plasma donations particularly role causing hypogammaglobulinemia predisposing individual severe bacterial infections study necessary explore effect immunoglobulin depletion plasma donation role development severe infection increased mortality",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40818041/",
        "source_type": "Global"
    },
    {
        "pmid": "40817233",
        "title": "Standard treatment regimen with and without dexamethasone on outcome of children aged 3-7 years with empyema: a randomized double blind clinical trial.",
        "abstract": "Corticosteroids effective inhibitory effect inflammatory factor used adjunctive therapy viral pneumonia conducted study compare effect standard treatment regimen without dexamethasone outcome 37yearold child empyema randomized controlled trial conducted university hospital Iran June 2023 November 2024 Children aged 37 year empyema enrolled patient received standard antibiotic treatment Vancomycin Meropenem fibrinolytic agent alteplase dexamethasone group received additional intrapleural dexamethasone injections Randomization performed using block randomization block size 4 child outcome assessor blinded dexamethasone administration primary outcome length stay LOS secondary outcome including duration fever chest tube placement oxygen saturation CRP levels 47 patient dexamethasone group  23 489 subject n  23 girls LOS dexamethasone group median 95 day range 717 days significantly less control group median 16 day range 1024 days duration fever median 5 vs 11 days CRP level median 125 vs 21 dexamethasone group significantly lower control group significant difference observed two group term PCR COVID19 influenza pleural fluid smear culture blood culture oxygen saturation duration chest tube placement finding showed use dexamethasone decrease duration hospitalization duration fever CRP levels leading faster recovery child empyema Dexamethasone safe effective adjunctive therapy empyema children IRCT20240705062336N1 Retrospectively Registered 20241116",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40817233/",
        "source_type": "Global"
    },
    {
        "pmid": "40815640",
        "title": "Functional and epitope specific monoclonal antibody discovery directly from immune sera using cryo-EM.",
        "abstract": "Antibodies crucial therapeutics comprising substantial portion approved drug due safety clinical efficacy Traditional antibody discovery method laborintensive limiting scalability highthroughput analysis Here improved upon streamlined approach combining structural analysis bioinformatics infer heavy light chain sequence cryoEM cryoelectron microscopy map serumderived polyclonal antibody pAbs bound antigens Using ModelAngelo automated structurebuilding tool accelerated pAb sequence determination identified sequence match B cell repertoire via ModelAngeloderived hidden Markov model HMMs associated pAb structures Benchmarking result nonhuman primate HIV vaccine trial pipeline reduced analysis time week day higher precision Validation murine immune serum influenza vaccination revealed multiple protective antibodies workflow enhances antibody discovery enabling faster accurate mapping polyclonal response broad application vaccine development therapeutic antibody discovery",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40815640/",
        "source_type": "Global"
    },
    {
        "pmid": "40812022",
        "title": "The impact of egg adaptation and immune imprinting on influenza vaccine effectiveness.",
        "abstract": "influenza vaccine produced hens egg may undergo egg adaptation whereby mutation within haemagglutinin protein result adaptation avian cell undergo positive selection well established egg adaptation impact antigenicity vaccine effectiveness VE causing mismatch vaccine virus circulating viruses However study investigated potentially longlasting impact childhood vaccination eggadapted vaccine immunological memory Prior exposure history shape subsequent immune responses memory response previously encountered antigen trigger stronger immune response elicited de novo antigen exposure phenomenon called immune imprinting referring specifically impact first lifetime exposure antigenic seniority referring exposure first also shape individuals antibody repertoire according early often encountered Crucially individuals first influenza exposure via eggadapted vaccine imprinting event could adversely affect antibody response circulating virus future seasons reducing benefit influenza vaccination Using alternative type vaccine avoid egg adaptation particularly important World Health Organization WHO recommend immunising child aged ≥6 month influenza review cover historical frequency nature egg adaptation impact egg adaptation immune imprinting antigenic seniority clinical effectiveness seasonal influenza vaccinations discus impact interaction egg adaptation immune imprinting examine eggadapted vaccine lead suboptimal imprinting potentially reduce throughout individuals lifetime identify address issue future",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40812022/",
        "source_type": "Global"
    },
    {
        "pmid": "40812020",
        "title": "From first infection to reinfection: Comparing Nucleocapsid antibody kinetics in vaccinated and unvaccinated adults.",
        "abstract": "Determining infection history individual prior immunity critical studying SARSCoV2 imprinting vaccine responses better understand response infection examine nucleocapsid protein antibody dynamic around first second SARSCoV2 infection vaccinated unvaccinated adults presence level nucleocapsidantibodies measured around first second SARSCoV2 infections Antibody waning measured accelerated failure time models firstinfections 958  885986  unvaccinated 894  865917  vaccinated participant seroconverted Vaccinated adult 455  shorter seropositivity event time ratio  055 95 CI 045066 secondinfections 891  769953  vaccinated 944  742990  unvaccinated participant 4fold rise antibody levels Regardless vaccination antibody level secondinfections significantly higher firstinfections finding suggest nucleocapsid serology inform researcher past infection regardless exposure status potentially differentiate initial infection reinfections",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40812020/",
        "source_type": "Global"
    },
    {
        "pmid": "40811481",
        "title": "Euglycemic Diabetic Ketoacidosis in Pregnancy.",
        "abstract": "Diabetic ketoacidosis pregnancy rare serious complication caused insulin deficiency Hyperglycemia considered hallmark sign diabetic ketoacidosis however physiologic change pregnancy predispose pregnant woman developing euglycemic diabetic ketoacidosis plasma glucose level normal near normal Euglycemic diabetic ketoacidosis pregnancy pose many challenge diagnosis including sign symptom attributed pregnancy rapid progression sign symptoms nearnormal glucose levels Fetal acidosis also develops result maternal disease process fetal heart rate tracing diabetic ketoacidosis often feature minimal absent variability fetal tachycardia recurrent late decelerations Treatment focus correcting maternal acidosis electrolyte imbalances Despite state fetal heart rate tracing birth typically indicated fetal status improve time correcting maternal acidosis improve outcome prevent worsening complications early diagnosis intervention vital patient diabetic ketoacidosis collaborative multidisciplinary approach patient facilitate timely diagnosis initiation treatment present case study patient diagnosed euglycemic diabetic ketoacidosis secondary influenza required emergency cesarean birth due worsening maternal fetal status despite corrective interventions",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40811481/",
        "source_type": "Global"
    },
    {
        "pmid": "40810539",
        "title": "Six-year retrospective analysis of the epidemiology and risk factors of multidrug-resistant bloodstream infections in oncology patients in Jiangxi, China.",
        "abstract": "Cancer patient particularly vulnerable bloodstream infection BSIs due immunocompromised status retrospective study Jiangxi Cancer Hospital 2019 2024 analyzed bacterial spectrum risk factors antimicrobial susceptibility profile BSIs cancer patients Logistic regression analysis performed identify risk factor associated multidrug resistance MDR Grampositive Gramnegative infections total 1161 bacteria isolated 954 oncological patient 1095 BSI episodes Among these 6279 Gramnegative bacteria iEscherichia colii 4088 iKlebsiella pneumoniaei 1907 prevalent Grampositive bacteria accounted 3721 isolates iStaphylococcus aureusi 2616 common Gramnegative infection prevalent patient breast gastrointestinal hepatobiliary pancreatic cancers whereas Grampositive infection common among lymphoma head neck lung cancers well patient undergoing invasive procedures High resistance rate observed ampicillin piperacillin cefazolin erythromycin whereas tigecycline nitrofurantoin exhibited low resistance rate among tested bacterial isolates Among Gramnegative bacteria 548 carbapenemase producer 1536 extendedspectrum βlactamase ESBL producers Moreover methicillin resistance observed 3604 iStaphylococcus aureusi 6683 coagulasenegative iStaphylococcusi isolates MDR observed 4019 Gramnegative 5092 Grampositive infections Hypoproteinemia OR 32 identified independent risk factor MDRBSIs caused Gramnegative bacteria high prevalence MDR bacteria BSIs among cancer patient highlight necessity individualized treatment continuous monitoring oncology settingsIMPORTANCEThis study address critical gap understanding epidemiology risk factor multidrugresistant bloodstream infection MDRBSIs oncology patient highburden region China analyzing thousand BSI episode 6 years study identifies predominant bacterial species resistance profiles key clinical procedural risk factor associated MDR high rate MDR among Gramnegative Grampositive pathogen underscore urgent need tailored antimicrobial stewardship infection control interventions individualized treatment strategies finding provide essential evidence guiding empirical antibiotic choice improving infection management protocol cancer care settings",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40810539/",
        "source_type": "Global"
    },
    {
        "pmid": "40806558",
        "title": "Unravelling the Viral Hypothesis of Schizophrenia: A Comprehensive Review of Mechanisms and Evidence.",
        "abstract": "Schizophrenia challenging multifactorial neuropsychiatric disease involves interaction genetic susceptibility environmental insults Increasing evidence implicates viral infection significant environmental contributors particularly sensitive neurodevelopmental periods review synthesis current finding viral hypothesis schizophrenia encompassing wide array neurotropic viruses including influenza viruses herpesviruses HSV1 2 CMV VZV EBV HHV6 8 hepatitis B C viruses HIV HERVs HTLV Zika virus BoDV coronaviruses including SARSCoV2 others pathogen contribute schizophrenia mechanism direct microinvasion persistent central nervous system infection immunemediated neuroinflammation molecular mimicry disturbance bloodbrain barrier Prenatal exposure viral infection trigger maternal immune activation resulting cytokinemediated alteration neurological development foetus persist adulthood Genetic study highlight role immunerelated loci including major histocompatibility complex polymorphisms modulating susceptibility infection neurodevelopmental outcomes Clinical data also support mild encephalitis hypothesis suggesting subset schizophrenia case involve lowgrade chronic neuroinflammation Although antipsychotic immunomodulatory effects adjunctive antiinflammatory therapy show promise particularly treatmentresistant cases Despite compelling associations pathogenspecific link remain inconsistent emphasising need longitudinal study integrative approach viromics unravel causal relationships review support multihit model viral infection interfere hereditary immunological susceptibilities enhancing schizophrenia risk Elucidating virusimmunebrain interaction may facilitate discovery biomarkers targeted prevention novel therapeutic strategy schizophrenia",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40806558/",
        "source_type": "Global"
    },
    {
        "pmid": "40803632",
        "title": "Antibiotic susceptibility according to age of clinical strains from hospital respiratory samples: A nationwide study.",
        "abstract": "study evaluated microbiological distribution sensitivity clinical strain respiratory sample inpatient antibiotic usually recommended treatment lower respiratory tract infection LRTI Using French SPARES Surveillance et Prévention de lAntibioRésistance en Etablissement de Santé database recorded respiratory microbiological sample collected 2022 409 hospital located region France distribution main bacterial specie resistance frequently prescribed antibiotic LRTI compared age group 1864 years 6579 years ≥ 80 years Among 48721 strains 477  isolated patient aged 1864 years 379  aged 6579 years 144  aged ≥ 80 years Enterobacteriaceae 301  360  351  respectively Pseudomonas aeruginosa 190  250  271  prevalent pathogens especially older patients Conversely Haemophilus influenzae 145  107  87  Streptococcus pneumoniae 83  56  34  rare older age Overall antibiotic resistance increased age across classes increasing order resistance levofloxacin 92  111  132  piperacillintazobactam 145  168  174  cefotaxime 274  343  395  doxycycline 282  374  395  cotrimoxazole 321  385  402  amoxicillinclavulanate 372  460  514  p  005 comparisons half strain resistant amoxicillin erythromycin large nationwide database respiratory samples older age associated high prevalence Enterobacteriaceae P aeruginosa betalactam resistance finding challenging current LRTI probabilistic treatment Conversely H influenzae S pneumoniae rarely observed patient 80 year age",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40803632/",
        "source_type": "Global"
    },
    {
        "pmid": "40803361",
        "title": "Clinical Characteristics of Influenza Pneumonia in Patients with Lung Adenocarcinoma Receiving Immunotherapy.",
        "abstract": "objective study examine general characteristics clinical manifestations laboratory findings imaging feature patient lung adenocarcinoma develop influenza pneumonia undergoing immunotherapy retrospective analysis conducted clinical data 48 patient lung adenocarcinoma pulmonary infection received immunotherapy standalone treatment September 2022 September 2024 Affiliated Hospital North China University Science Technology Clinical characteristic patient concurrent influenza pneumonia assessed compared noninfluenza pneumonia group patient influenza pneumonia group demonstrated significantly severe systemic symptoms elevated urea nitrogen levels reduced platelet counts decreased serum albumin levels lower Prognostic Nutritional Index values higher prevalence bilateral multilobed lung involvement Chest imaging frequently revealed ground glass opacities reticular patterns crazy paving sign Additionally group exhibited higher CURB65 score increased need intensive care unit admission comparison yielding ipi value 005 Hypotension emerged potential factor influencing mortality group odds ratio  9094 ipi  0041 Among 19 patient lung adenocarcinoma influenza pneumonia 895 coinfections pathogens Gramnegative bacterial infection common 647 iKlebsiella pneumoniaei subspecies iPseudomonas aeruginosai iHaemophilus parainfluenzaei identified leading pathogens Fungal infections primarily involving iAspergillusi species accounted 235 cases General characteristics clinical manifestations laboratory findings imaging feature essential reference diagnosis management lung adenocarcinoma complicated influenza pneumonia Particular attention directed blood pressure fluctuations careful monitoring low blood pressure especially accompanied bacterial infections",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40803361/",
        "source_type": "Global"
    },
    {
        "pmid": "40803328",
        "title": "Clonotype-enriched somatic hypermutations drive affinity maturation of a public human antibody targeting an occluded sarbecovirus epitope.",
        "abstract": "Investigating public antibody recognize conserved epitope critical vaccine development Identifying somatic hypermutations SHMs enhance antigen affinity public antibody key guiding vaccine design better protection pathogens propose affinityenhancing SHMs selectively enriched public antibody clonotypes surpassing background frequency seen antibody carrying V gene different epitope specificities Using M15 human IGHV459IGKV320 public antibody model compare SHM signature antibody use V gene recognize epitopes identified clonotypeenriched mutation light chain M15 showed that combination SHMs enhance binding previously uncharacterized Sarbecovirus epitope antibody response increasing sequential vaccination finding identify convergence clonotype enrichment feature affinityenhancing SHMs public antibodies help guide vaccine design aimed eliciting antibodies",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40803328/",
        "source_type": "Global"
    },
    {
        "pmid": "40802690",
        "title": "Mechanistic insights into the small-molecule inhibition of influenza A virus entry.",
        "abstract": "Influenza virus IAV zoonotic pathogen responsible seasonal pandemic flu extensive genetic antigenic diversity within IAV phylogenetic group present major challenge developing universal vaccine broadspectrum antiviral therapies Current intervention provide limited protection due viruss high mutation rate capacity immune evasion Recent advancement viral hemagglutinin HAtargeting smallmolecule entry inhibitor offer promising avenue overcome limitations Here present structural functional analysis two group 2 HAspecific smallmolecule inhibitor recently identified team Cryogenic electron microscopy cryoEM structure revealed inhibitor bind conserved pocket within HA stalk likely interfering conformational rearrangement necessary membrane fusion viral entry Structureguided mutagenesis confirmed critical role key interacting residue uncovered distinct resistance profile two compounds well comparison Arbidol previously reported HA inhibitor Notably structural analysis highlight intrinsic barrier achieving crossgroup inhibition current smallmolecule designs address this propose alternative strategy broadening antiviral coverage Together finding provide mechanistic insight IAV entry inhibition foundation rational design nextgeneration antiinfluenza therapeutics",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40802690/",
        "source_type": "Global"
    },
    {
        "pmid": "40797503",
        "title": "Clinical characteristics and management of co-infected patients of influenza A and Aspergillus: Case series in the Southern China.",
        "abstract": "Influenza Aspergillus coinfection topic significant interest report 5 patient influenza Aspergillus coinfection of Upon admission patient diagnosed influenza virus infection elevated level inflammatory markers including Creactive protein serum amyloid A patient treated antiviral therapy upon admission Computed tomography imaging 5 10 day later detected improvement investigation indicated patient exhibited sign acute Aspergillus infection showing halo sign solidification along bronchi One patient diagnosed coinfection biopsy remaining patient diagnosed clinically based least 2 diagnostic marker such bloodBALF GM tNGS sputum culture coinfection diagnosis treatment supplemented antifungal voriconazole Followup computed tomography scan 4 patient revealed improvement 7 14 day antifungal treatment important note Aspergillus infection considered potential risk factor among patient influenza fail improve worsen despite receiving full antiviral treatment",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40797503/",
        "source_type": "Global"
    },
    {
        "pmid": "40796188",
        "title": "Clinician Preferences for Oseltamivir Use in Children With Influenza in the Outpatient Setting.",
        "abstract": "Professional society recommend antiviral treatment child high risk severe complicated influenza disease regardless symptom duration However outpatient antiviral prescribing practice inconsistent aimed assess pediatric clinicians outpatient prescribing practice oseltamivir child influenza vignettebased study pediatric clinician conducted March June 2024 7 US childrens hospital affiliated clinics survey included 4 clinical influenza vignettes 3 represented scenario warranting treatment per national recommendations One vignette randomized explore impact symptom duration treatment preferences primary outcome proportion vignette respondent likely somewhat extremely recommend oseltamivir 1124 eligible participants 452 402 responded survey Successive wave analysis revealed evidence response bias Participants likely recommend oseltamivir 362 cases variation among specialty 296 emergency medicine 372 general pediatrics 486 infectious diseases P  001 among study site 286 507 P  018 adjusted clustering Longer symptom duration 2 v 4 days significantly decreased respondents likelihood recommend oseltamivir 309 18 P  001 demonstrate considerable nonadherence national influenza treatment recommendation variability regarding outpatient use oseltamivir treat child influenza indicates uncertainty perceived benefit oseltamivir relatively healthy pediatric population nonsevere disease Treatment standardization accordance national guideline rigorous monitoring subsequent outcome needed",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40796188/",
        "source_type": "Global"
    },
    {
        "pmid": "40794954",
        "title": "An advanced network pharmacology investigation of Shufeng Jiedu formula in the treatment for respiratory tract infection based on LC-MS, data mining, molecular docking, and molecular dynamic simulation.",
        "abstract": "Respiratory tract infection RTI continues nonnegligible cause global incidence rate mortality Shufeng Jiedu formula SFJD traditional Chinese remedy used treating RTI though mechanism well understood objective research uncover underlying molecular mechanism responsible effectiveness SFJD RTI Using UHPLCQOrbitrap HRMS assays chemical compound SFJDs ethanol aqueous extract fraction identified target herbal compound RTIrelated target acquired various database Key SFJDRTI target analyzed using Gene Ontology GO Kyoto Encyclopedia Genes Genomes KEGG tissueorganspecific analyses Molecular docking data mining dynamic simulation employed evaluate interaction major target main compounds total 94 31 compound determined aqueous ethanol extract fraction respectively Many compound demonstrated good oral bioavailability 6099 GO analysis revealed significant involvement inflammatory response gene silencing processes KEGG pathway highlighted connection viral infection signaling pathways lung primary target organ screed Biogps database 15 compound well eight key gene associated set 15 compound virtually fitted active site eight critical targets Isaindigotone resveratrol could form hydrogen bond interaction FOS JUN respectively FOS JUN classified differential gene COVID2019 HCoV229E H1N1 infected comprehensive result obtained MD simulation MMPBSA SASA analysis highlighted compounds potential serve effective inhibitor FOS JUN proteins Lastly resveratrol exerted high inhibitory effect influenza virus based MDCK cells summary provided framework integrated network pharmacology multiple virus infection model identify synergistic compound based network topology",
        "mesh_terms": [
            "Network Pharmacology",
            "Drugs, Chinese Herbal",
            "Molecular Docking Simulation",
            "Data Mining",
            "Humans",
            "Molecular Dynamics Simulation",
            "Respiratory Tract Infections",
            "Chromatography, Liquid",
            "Liquid Chromatography-Mass Spectrometry"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40794954/",
        "source_type": "Global"
    },
    {
        "pmid": "40793762",
        "title": "Rapid molecular detection of respiratory pathogens in patients admitted with suspected community-acquired pneumonia: secondary analysis of a randomized controlled trial.",
        "abstract": "randomized trial demonstrated implementing pointofcare POC PCR detection respiratory pathogen emergency department ED setting change overall antibiotic use led targeted treatment clinically relevant albeit nonsignificant reduction length stay study aimed assess diagnostic impact POCPCR testing patient suspected communityacquired pneumonia CAP ED study secondary analysis Danish multicenter randomized controlled trial RCT included patient aged ≥18 year admitted ED March 2021 February 2022 primary trial patient randomly assigned one two parallel groups i intervention group POCPCR addition standard care ii control group standard care SCO present secondary analysis focus exclusively patient intervention group POCPCR standard culturebased diagnostics performed diagnosis CAP determined expert panel intervention group 145 patient lower respiratory tract LRT specimen analyzed using POCPCR culture POCPCR identified notably microorganism compared culture 187 v 34 agreement positive result obtained POCPCR culture 6 19 316 iStreptococcus pneumoniaei 16 61 26 iHaemophilus influenzaei Concentrations ≥10sup7sup copiesmL detected POCPCR iS pneumoniaei iH influenzaei associated diagnosis CAP 67 patient identified iS pneumoniaei andor H iinfluenzaei 46 69 received targeted treatment 57 85 received adequate treatment 10 15 received inappropriate treatment rapid pathogen detection POCPCR likely improve diagnostic accuracy promote appropriate use antibiotic CAP patients finding suggest pointofcare POCPCR testing significantly enhance diagnostic accuracy CAP emergency department ED thereby facilitating targeted effective antimicrobial treatment light growing concern antimicrobial resistance pressing need rapid diagnostics acute care settings believe study hold considerable relevance clinical practice ED",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40793762/",
        "source_type": "Global"
    },
    {
        "pmid": "40793352",
        "title": "Thermogenesis dynamics and influenza A virus: unveiling the intriguing interplay.",
        "abstract": "Maintaining body temperature critical brown adipose tissue BAT uuncoupling protein 1 UCP1u activation playing pivotal role heat generation metabolism Modulating thermoregulation pathway BAT help alleviate fever enhance metabolic wellbeing boost immune function viral infection influenza A review explores intricate link thermogenesis influenza virus IAV highlighting IAV impact body temperature regulation immune responses Mitochondrias function energy production heat generation UCP1mediated thermogenesis underscore significance regulating body temperature metabolic rate responsiveness environmental cue like cold exposure Understanding interplay among mitochondria UCP1 thermoregulation offer insight potential therapeutic intervention managing IAV infections regulatory mechanism governing thermogenesis influence adipose tissue thermogenesis various pathways affecting body temperature metabolic functions Additionally review underscore potential therapeutic target within thermogenesis pathway associated IAV infection regulatory mechanism improve prevention treatment strategies review underscore pivotal role thermogenesis mitochondrial function hosts response IAV infections emphasizing need research enhance management strategies",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40793352/",
        "source_type": "Global"
    },
    {
        "pmid": "40788911",
        "title": "Pneumococcal vaccination at 65 years and vaccination coverage in at-risk adults: A retrospective population-based study in France.",
        "abstract": "Age  50 years risk factor pneumococcal disease indication vaccination France contrast influenza 2018 pneumococcal vaccine coverage rate VCR 45 adult atrisk contrast influenza VCR 436 aimed assess pneumococcal influenza VCR 2020 entire French population factor associated higher VCR including age 65 years retrospectively included adult covered National Health Service 2020 identified patient atrisk using validated algorithms assessed VCRs analysing pneumococcal vaccine reimbursed 2009 2020 13valent pneumococcal conjugate vaccine PCV13 23valent polysaccharide vaccine PPSV23 influenza vaccine reimbursed September 2020 March 2021 2020 identified 7336769 adult risk median age 670 years 842 comorbidities 245 immunocompromised overall pneumococcal VCR PCV13  PPSV23 99 seasonal influenza VCR 511 variable associated highest odds VCR age ≥65 years influenza odds ratio OR 414 pneumococcal vaccination OR 102 patient comorbidities pneumococcal VCR significantly increase aged 1865 year aged  65 year 72 94 even decreased 20 179 patient immunodeficiencies contrast influenza VCR increased significantly 355 679 OR 355 patient comorbidities 273 712 OR 557 immunodeficiencies France pneumococcal VCR increase 65 year age OR 102 contrast influenza VCR OR 414 increased significantly suggesting agebased recommendation pneumococcal vaccination probably benefit VCR atrisk elderly population",
        "mesh_terms": [
            "Humans",
            "Aged",
            "France",
            "Pneumococcal Vaccines",
            "Male",
            "Retrospective Studies",
            "Female",
            "Middle Aged",
            "Vaccination Coverage",
            "Pneumococcal Infections",
            "Adult",
            "Aged, 80 and over",
            "Vaccination",
            "Risk Factors",
            "Influenza Vaccines",
            "Young Adult",
            "Influenza, Human"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40788911/",
        "source_type": "Global"
    },
    {
        "pmid": "40788183",
        "title": "Clinical Evaluation of M1-c6v1 Oncolytic Virus Combined with Camrelizumab and Apatinib in Advanced Hepatocellular Carcinoma.",
        "abstract": "study evaluated safety tolerability preliminary efficacy M1c6v1 oncolytic virus combined immune checkpoint inhibitor ICIs camrelizumab vascular endothelial growth factor receptor 2 VEGFR2 inhibitor apatinib advanced hepatocellular carcinoma HCC singlearm investigatorinitiated openlabel clinical trial enrolled patient advanced HCC NCT04665362 Patients received M1c6v1 1×10⁹ CCID50 intravenously 5 day every 28 days camrelizumab 200 mg intravenously biweekly apatinib 250 mg orally daily Treatment continued 1 year disease progression intolerability withdrawal Primary endpoint safety tolerability secondary endpoint assessed efficacy based tumor response progressionfree survival PFS overall survival OS Thirteen patient enrolled 846 hepatitis B virus HBVrelated HCC 769 presenting tumor 10 cm treatment welltolerated 9215 adverse event AEs grade 1 2 common AEs included influenzalike symptom transient cytopenia viral shedding detected secretion excretion collected subjects 10 patient evaluable efficacy overall response rate ORR 70 710 7 partial response PR according mRECIST median OS PFS 154 89 month respectively combination M1c6v1 camrelizumab apatinib demonstrates acceptable safety profile promising efficacy advanced HCC",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40788183/",
        "source_type": "Global"
    },
    {
        "pmid": "40788012",
        "title": "Heat shock protein A1L restricts influenza A virus by ubiquitination of NA.",
        "abstract": "Neuraminidase NA protein influenza virus IAV tetrameric envelope glycoprotein critical viral release spread wellcharacterized enzymatic function poorly resolved hostpathogen interactions However host factor targeted NA regulating NA activity largely uncharacterized Here identified host heat shock protein A1L HSPA1L novel NAbinding partner suppresses IAV replication Subsequent study revealed HSPA1L promotes NA ubiquitination K242 resulting NBR1dependent autophagic degradation Moreover recombinant H5N1 virus carrying NAsupK242Rsup mutation exhibited enhanced replication resistance HSPA1Lmediated viral suppression compared wildtype WT virus Collectively unveil intrinsic defense mechanism wherein HSPA1L antagonizes IAV promoting NBR1dependent autophagic degradation NA via sitespecific ubiquitinationIMPORTANCEIAV especially avian influenza virus H5N1 begin cause infection andor death new uncommon host especially sea mammal ruminants indicating virus adapting mammalian infections development substantially elevate concern pandemic potential zoonotic risk escalation necessitating deeper understanding hostIAV interaction develop effective antiviral countermeasures HSP70 family protein known modulate viral infections However specific role HSPA1L member HSP70 family IAV infection remains poorly characterized study demonstrate HSPA1L defends IAV regulating NA proteostasis Mechanistically HSPA1L directly bind NA promotes ubiquitination K242 mediates NBR1dependent autophagic degradation thereby suppressing viral replication study identifies HSPA1L promising target antiviral strategy IAV",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40788012/",
        "source_type": "Global"
    },
    {
        "pmid": "40787259",
        "title": "Qingwen Hufei Granules Attenuate Lipopolysaccharide-Induced Acute Lung Injury by Suppressing NLRP3 Inflammasome-Dependent Pyroptosis.",
        "abstract": "Currently clinical treatment ALI include vasodilators glucocorticoids mechanical ventilation however therapy associated various adverse reactions Therefore need develop safer effective treatment options Traditional Chinese Medicine TCM particularly Qingwen Hufei Granules QHG demonstrated efficacy treating respiratory disorders including upper respiratory tract infection influenza However active component mechanism action QHG remain unclear Lipopolysaccharide LPS induced ALI mouse model analyzed main pharmacodynamic component QHG HPLC determined effect QHG cell viability inflammatory factor RAW2647 cells recorded body weight lung tissue wetdry WD ALI mice Inflammatory factor bronchoalveolar lavage fluid BALF serum lung tissue determined using ELISA protective effect hematoxylin eosin HE staining lung tissue studied Transcriptomic qRTPCR Western blotting immunohistochemistry immunofluorescence analysis used analyze QHG explore mechanism ALI damage reduction finding demonstrated QHG effectively mitigated inflammatory cell invasion pulmonary edema Moreover diminished concentration IL6 TNFα IL1β lung tissue serum BALF Furthermore QHG notably decreased level NO reactive oxygen speciesROS IL6 IL1β TNFα supernatant RAW2647 cells Transcriptomic analysis lung tissue revealed QHG primarily enriched NODlike receptor NLR signaling pathway qRTPCR Western blotting immunohistochemistry immunofluorescence experiment confirmed QHG mitigated ALI damage NLR signaling pathway Furthermore seven key component QHG determined using HPLC study demonstrated QHG effectively mitigated LPSinduced ALI provided preliminary insight mechanism action material basis",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40787259/",
        "source_type": "Global"
    },
    {
        "pmid": "40786761",
        "title": "Haemophilus influenzae Acute Prosthetic Joint Infection: A Rare Case Report on Time-Critical, Pathogen-Specific Management.",
        "abstract": "Prosthetic joint infection PJIs serious complication arthroplasty often necessitating prolonged therapy revision surgeries Haemophilus influenzae uncommon cause PJI especially immunocompromised individual individual comorbidities fastidious nature frequently lead negative cultures delaying diagnosis targeted therapy report case 52yearold male rheumatoid arthritis immunosuppressive therapy presented acute right hip pain swelling purulent wound discharge 3 month revision total hip arthroplasty Initial workup revealed elevated inflammatory marker sign joint infection JI Conventional microbiological method including Gram stain acidfast bacillus testing enrichment culture inconclusive However syndromic multiplex polymerase chain reaction PCR using BioFire® JI panel detected H influenzae within 2 h intraoperative sample collection patient underwent debridement targeted antibiotic therapy implant retention DAIR Empirical therapy meropenem vancomycin promptly deescalated intravenous ceftriaxone based PCR results Clinical recovery marked rapid decline Creactive protein resolution symptoms successful switch oral therapy 6week 16week followup patient asymptomatic normal inflammatory marker radiographs functioning retained implant case underscore clinical value rapid syndromic testing detecting rare fastidious pathogen like H influenzae PJIs early identification facilitated timely DAIR targeted antibiotic therapy reduced hospital stays preserved implant approach highlight role molecular diagnostics enhancing antimicrobial stewardship improving clinical outcome complex orthopedic infections",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40786761/",
        "source_type": "Global"
    },
    {
        "pmid": "40786610",
        "title": "Nanobodies in animal infectious disease control: diagnosis and therapy.",
        "abstract": "Animal infectious disease threaten livestock productivity public health food security Traditional monoclonal antibody mAbs face limitation diagnostics therapy due large size instability high cost Nanobodies Nbs derived camelid heavychain antibodies offer superior propertiessmall size 15 kDa high stability deep tissue penetration costeffective production Nbs feature extended CDR3 loops enabling access cryptic epitopes exhibit exceptional thermalpH stability generated immunizing camelids cloning VHH genes screening via phageyeast display Highthroughput method ELISA flow cytometry allow rapid isolation highaffinity Nbs Compared mAbs Nbs economically produced prokaryotic system engineered multivalent Fcfused format enhanced efficacy diagnostics Nbs enable sensitive lowcost detection pathogen like PRRSV ASFV avian influenza Nbbased competitive ELISAs lateral flow assay improve field surveillance Therapeutically Nbs neutralize pathogen targeting viral protein eg blocking PRRSVCD163 entry bacterial toxin eg Staphylococcus enterotoxins NbFc fusion degrade ASFV protein via TRIMaway intracellular Nbs disrupt Mycobacterium ESAT6 Toxoplasma actin dynamics Challenges remain Nb affinity optimization intracellular delivery iin vivoi halflife Solutions include fusion cellpenetrating peptide viral vector eg adenoviruses Reducing crossspecies immunogenicity scaling production critical broader adoption advance protein engineering Nbs hold transformative potential preventing diagnosing treating animal diseases offering scalable solution global health food security",
        "mesh_terms": [
            "Animals",
            "Single-Domain Antibodies",
            "Animal Diseases",
            "Communicable Disease Control",
            "Communicable Diseases"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40786610/",
        "source_type": "Global"
    },
    {
        "pmid": "40780374",
        "title": "Gut derived (S)-Equol mitigates influenza viral pneumonia by modulating macrophage polarization via Nrf2 mediated AKT/ERK/NF-κb signaling pathways.",
        "abstract": "Respiratory virus including influenza virus IAV infection induces alteration gut microbiota structure function turn play essential role pathogenic process Alterations gut microbiota usually accompanied change metabolites specific relationship dynamic change gut microbiota serum metabolite influenza remains unclear study depicted dynamic change composition gut microbiota using metagenomic sequencing influenza mouse model mass spectrometry based metabolomic identified SEquol notable protective metabolite derived intestinal flora Serum SEquol level decreased initial infection phase increased gradually convalescence phase positively associated change Eggerthella Bifidobacterium species Antibiotic treatment reduced serum SEquol level exacerbated lung pathological damage Oral administration SEquol relieved disease severity controlled inflammatory infiltration Mechanistically SEquol activated Nrf2 macrophages thereby inhibited AKT ERK NFκB phosphorylation inhibition signaling pathway ultimately restrained proinflammatory cytokine release repressed proinflammatory macrophage polarization Moreover serum SEquol level lower influenza patient progressed phase negatively correlated serum level IL6 IL1β TNFα Collectively data highlighted gut derived SEquol promising postbiotic alleviating influenza pneumonia",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40780374/",
        "source_type": "Global"
    },
    {
        "pmid": "40780338",
        "title": "IAV inhibits the host antiviral defense mediated by LncRNA-LRIR to enhance viral replication.",
        "abstract": "Long noncoding RNAs lncRNAs defined transcript longer 200 nucleotidesnt proteincoding potential Accumulating evidence indicates interaction lncRNAs influenza virus IAV play crucial role multiple biological processes including host antiviral immunity regulating viral replication However mechanism IAV resists antiviral immunity enhances replication inhibiting lncRNAmediated antiviral defense remain largely unexplored study identified lncRNA designated LRIR LncRNA Regulating IAV Replication significantly downregulated upon IAV infection A549 cells Notably LRIR knockdown significantly promotes IAV replication whereas LRIR overexpression inhibits viral replication suggesting LRIR exerts antiviral effect IAV infection Furthermore antiviral activity LRIR primarily depends region spanning 258 381 nt 3897 nt Mechanistically LRIR found inhibit replication transcription viral genome study indicated LRIR suppresses IAV replication downregulating expression transmembrane protease serine 2 TMPRSS2 Collectively finding reveal IAV infection suppresses LRIR expression thereby weakening negative regulation TMPRSS2 subsequently promoting viral replication result provide theoretical foundation development novel antiIAV therapeutics",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40780338/",
        "source_type": "Global"
    },
    {
        "pmid": "40778490",
        "title": "Clinical Characteristics of Patients With Respiratory Infections After Nonpharmacological Interventions for COVID-19 in China Have Ended: Using Machine Learning Approaches to Support Pathogen Prediction at Admission.",
        "abstract": "aftermath COVID19 pandemic China witnessed surge respiratory virus infections presented considerable challenge primary health care systems study developed interpretable prediction model using complete blood count CBC test data model aim identify common respiratory virus infection patients studys derivation cohort included 7471 patient presented fever Central Hospital November December 2023 patient underwent diagnostic procedures including influenza Flu A Mycoplasma pneumoniae MP antibody testing CBC basis result CBC patients basic information modelling prediction machine learning ML performed external verification conducted Among developed models constructed two distinct version threeclass model one emphasizing high recall balancing precision recall final model refined manual parameter adjustment comprehensive network search highrecall model demonstrated superior performance detecting Flu A recall rate 810 Conversely precision‒recall balanced model exhibited enhanced accuracy identifying MP cases precision rate 843 interpretable ML model achieves accurate identification Flu MP infection febrile patient also address prevalent black box concern associated ML techniques technique aid clinician enhancing diagnostic efficiency accuracy Therefore improvement lead reduced medical expense minimizing unnecessary test treatments",
        "mesh_terms": [
            "Humans",
            "Machine Learning",
            "COVID-19",
            "China",
            "Male",
            "Female",
            "Middle Aged",
            "Influenza, Human",
            "Adult",
            "SARS-CoV-2",
            "Respiratory Tract Infections",
            "Aged",
            "Pneumonia, Mycoplasma",
            "Blood Cell Count",
            "Influenza A virus"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40778490/",
        "source_type": "Global"
    },
    {
        "pmid": "40778160",
        "title": "Effective Aerosol Inoculation of Dose-Escalated Seasonal Influenza H3N2 Virus in Controlled Human Infection Model.",
        "abstract": "Human challenge model CHIMs instrumental advancing influenza research traditionally relied intranasal inoculation mimic natural aerosol transmission virus conducted doseescalation influenza CHIM study evaluate safety feasibility two modern aerosol delivery systems flowfocusing monodisperse aerosol generator FMAG medical nebulizer Fourteen healthy adult aged 1849 year exposed influenza APerth162009 H3N2 controlled inpatient setting Infection rate 75 34 FMAG 50 24 nebulizer higher dose Infections selflimited sinus congestion rhinorrhea cough common symptoms serious adverse event occurred Viral shedding reproducible across respiratory sites seroconversion occurred 33 infected participants Symptom timing viral kinetics comparable observed prior intranasal CHIMs Participants receiving nebulizerdelivered virus showed earlier viral detection oral cavity suggesting broader airway deposition finding demonstrate aerosol influenza challenge safe effective simulate natural infection accurately intranasal delivery reintroduction aerosolized influenza challenge provides robust platform studying transmission dynamics tissuespecific immune responses evaluating nextgeneration vaccine therapeutic condition better approximate realworld exposure demonstrated controlled human infection doseescalated H3N2 influenza virus via two safe effective aerosolization route provide accurate simulation realworld exposure intranasal delivery studying influenza transmission tissuespecific immune responses vaccinestherapeutics",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40778160/",
        "source_type": "Global"
    },
    {
        "pmid": "40777507",
        "title": "Hybrid peptide DNA nanomaterials enable potent and broad-spectrum virus neutralization.",
        "abstract": "continued emergence antigenic drift drugresistant viral strain highlight need antiviral strategy deliver robust efficacy broad subtype coverage minimal offtarget toxicity demonstrate potent broadspectrum strategy employ hybrid biomaterials Urumin a host defense peptide honeycomb HC DNA origami spatially organized multivalent presentation enhanced antiviral efficacy Molecular dynamic simulation reveal Urumin penetrates destabilizes hemagglutinin HA trimer core disrupting influenza viral IAV entry Arranging Urumin trimeric cluster HC enables potent multivalent binding trimeric IAV enhancing antiviral efficacy nanomolar concentrations ∼1000fold effective free Urumin vitro assay confirm HCUrumin outperforms free Urumin blocking viral entry preserving cell viability IAV subtypes vivo study show compared free Urumin HCUrumin treatment reduces disease severity preserve physiological behavior decrease mortality infected mice maintaining virusspecific adaptive immune response without altering humoral immunity study offer advanced effective material platform strategy broadspectrum lowdose intervention human animal IAVs adapted combat virus patterning corresponding host defense peptide custom designed DNA nanostructures",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40777507/",
        "source_type": "Global"
    },
    {
        "pmid": "40776896",
        "title": "Increase in serogroup W invasive meningococcal disease in England associated with pilgrimage to Saudi Arabia, January 2024 to June 2025.",
        "abstract": "England experiencing increase serogroup W invasive meningococcal disease IMD caused strain A meningococcal sequence type 11 clonal complex MenWcc11 Hajj strain sublineage Travelassociated nontravelassociated meningococci four strain substrains A1A4 accounted 32 59 MenW IMD case January 2024 June 2025 14 people returning Saudi Arabia household contacts eight 14 linked Umrah pilgrimage Communications MenACWY vaccination pilgrim yearround reinforced",
        "mesh_terms": [
            "Humans",
            "Saudi Arabia",
            "Male",
            "England",
            "Adult",
            "Female",
            "Meningococcal Infections",
            "Neisseria meningitidis",
            "Travel",
            "Meningococcal Vaccines",
            "Middle Aged",
            "Adolescent",
            "Child",
            "Serogroup",
            "Young Adult",
            "Neisseria meningitidis, Serogroup W-135",
            "Aged",
            "Meningitis, Meningococcal",
            "Disease Outbreaks",
            "Child, Preschool"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40776896/",
        "source_type": "Global"
    },
    {
        "pmid": "40775301",
        "title": "A ductule dacryolith misdiagnosed as refractory conjunctivitis: a case report.",
        "abstract": "Dacryoliths located temporal canthus relatively rare presented case giant ductule dacryolith associated Haemophilus influenzae described clinical features female patient presented persistent secretion lateral canthal region right eye Surgical exploration performed bacterial culture tissue pathology analysis magnetic resonance imaging MRI examination completed huge ductule dacryolith found temporal canthus composed amorphous acidic substances bacterial culture result showed infection Haemophilus influenzae postoperative MRI result showed sign inflammation around lacrimal gland patients symptom disappeared immediately operation Ductule dacryoliths rare worth considering patient present unilateral lateral refractory conjunctivitis",
        "mesh_terms": [
            "Humans",
            "Female",
            "Diagnostic Errors",
            "Magnetic Resonance Imaging",
            "Conjunctivitis",
            "Lacrimal Duct Obstruction",
            "Lacrimal Apparatus Diseases",
            "Haemophilus Infections",
            "Eye Infections, Bacterial",
            "Calculi",
            "Haemophilus influenzae",
            "Dacryocystorhinostomy"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40775301/",
        "source_type": "Global"
    },
    {
        "pmid": "40775020",
        "title": "The efficacy and safety of inhaled peptide YKYY017 for COVID-19 patients with mild illness: a phase 2 randomized controlled trial.",
        "abstract": "YKYY017 SARSCoV2 membrane fusion inhibitor report efficacy safety inhaled YKYY017 COVID19 patient mild moderate illness phase 2 trial ChiCTR2300075467 239 patient aged 1875 year mostly mild COVID19 randomly allocated receive aerosol inhalation 10 20 mg YKYY017 placebo daily primary endpoint change SARSCoV2 viral load baseline Day 4 mean ±SE difference viral load change baseline 048 ± 027 logsub10sub copiesmL 95 CI 101 006 20 mg group 027 ± 027 logsub10sub copiesmL 95 CI 079 026 10 mg group compared placebo group Viral load change visit Day 4 differ significantly placebo either 10 20 mg YKYY017 groups time sustained symptom recovery shorter 20 mg YKYY017 group median 11753 95CI 9533 14145 hours placebo group median 14300 95CI 13917 18687 hours HR 1552 95CI 1089 2214 p  00151 whereas 10 mg YKYY017 group showed similar statistically significant trend compared placebo p  00833 time sustained symptom alleviation shorter 20 10 mg YKYY017 group placebo group adverse event mostly mild moderate primary outcome met Following supplementary phase 1b trial planning another phase 23 trial using twicedaily 20 mg YKYY017 regimen assess efficacy safety",
        "mesh_terms": [
            "Humans",
            "Middle Aged",
            "Adult",
            "Male",
            "Female",
            "SARS-CoV-2",
            "Administration, Inhalation",
            "Viral Load",
            "Aged",
            "COVID-19 Drug Treatment",
            "COVID-19",
            "Adolescent",
            "Young Adult",
            "Antiviral Agents",
            "Treatment Outcome",
            "Double-Blind Method"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40775020/",
        "source_type": "Global"
    },
    {
        "pmid": "40774301",
        "title": "[Immunosuppression in Cancer: Strategies for Infection Prevention].",
        "abstract": "Antimicrobial prophylaxis important cornerstone reducing morbidity mortality cancer patients Important stride made recent year vaccination drug prophylaxes use growthfactor support detail change respective recommendation herePatients malignant disease recommended receive vaccination common respiratory pathogen COVID19 influenza pneumococci RSV influenza now trivalent vaccine pneumococcus now PCV20 preferred vaccine changed VZV vaccination using inactivated virussubunit also recommended prevent reactivations profound Bcell depletion caused CART cell therapy increasingly considered vaccination recommendationsIn highrisk situations antibiotic prophylaxis using fluoroquinolones used However due increasing resistance significant side effects approach critically evaluatedPosaconazole recommended standard prophylaxis patient neutropenia 7 day 05GL hematologic malignancies Isavuconazole offer effective alternative patient cannot tolerate posaconazole Interactions antifungal agent oncological therapy becoming increasingly relevant particular attention CYP450enzyme inducinginhibiting substances Nonpharmacological measure prevent fungal infection part recommendations include smoking cessationPharmacological prophylaxis COVID19 generally recommendedThe threshold primary growthfactorsupport lowered GCSF generally recommended risk febrile neutropenia 20 or patient inherent risk factor present 10 new longacting nonPEGcontaining GCSF preparation approved 2024Good collaboration oncologist general practitioner essential translate recommendation clinical practice",
        "mesh_terms": [
            "Humans",
            "COVID-19",
            "Immunocompromised Host",
            "Neoplasms"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40774301/",
        "source_type": "Global"
    },
    {
        "pmid": "40773213",
        "title": "Geroscience: A Translational Review.",
        "abstract": "incidence stroke heart failure dementia many cancers coronary artery disease physical disability rise exponentially age Geroscience relatively new discipline aim define modify agingrelated biologic pathways slow agerelated disability prevent agerelated diseases increase disabilityfree survival Medical therapy typically alter biologic pathway treat prevent specific diseases example 3hydroxy3methylglutarylcoenzyme reductase inhibitor statins cholesterollowering medication used prevent development progression atherosclerosis However diseasefocused treatment alter agings effect disease declining function eg statin significantly reduce noncardiovascular mortality cancer animal models treatment alter agings effect disease example mice caloric restriction increase mean lifespan 10 40 compared mouse fed ad libitum favorably affect multiple cellular pathway implicated aging including nutrient sensing protein synthesis autophagy inflammation adult obesity diabetes compared noncaloric restriction intervention groups randomization receive caloric restriction associated 15 reduction allcause mortality lower incidence weightrelated chronic diseases Rapamycin drug approved suppress posttransplant organ rejection increased mouse median lifespan 249 day female 154 day males rapamycin analogue everolimus improved antibody titer influenza vaccine older adults humans senescent cell increase abundance age characterized growth arrest apoptosis resistance altered secretome the set protein secreted cell extracellular space greater abundance senescent cell associated physical impairment increased mortality Reducing number cell animal model extends lifespan improves physical function grip strength mobility cardiac ejection fraction However potential health benefit reducing senescent cell human remain unclear Therapies inhibit aging biology caloric restriction metformin senolytics rapalogs may slow development progression disease functional decline humans",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40773213/",
        "source_type": "Global"
    },
    {
        "pmid": "40773168",
        "title": "Using the CARD system for university-based pop-up vaccination clinics: A two-stage hybrid effectiveness-implementation study.",
        "abstract": "Mass vaccination clinic efficiently vaccinate large number people CARD system Comfort Ask Relax Distract vaccination delivery framework improve experience vaccine recipient providers twostage hybrid effectivenessimplementation study implemented sustained CARD universitybased vaccination clinic involving pharmacy student vaccinators Stage 1 beforeandafter study conducted across four COVID19 vaccination clinic NovemberDecember 2022 Stage 2 single cohort study whereby CARD sustained across four COVID19influenza vaccination clinic November 2023 stages vaccine recipient rated experience relative last vaccination iprimary outcomei symptom pain fear dizziness using surveys Pharmacy student vaccinator completed attitude behavior surveys subsample participated focus groups Stage 1 vaccine recipient period vs before reported better vaccination experience relative last vaccination 640 v 336 ipi  001 ini  181 Fear pain lower 11 vs 17 ipi  03 16 vs 21 ipi  02 respectively Stage 2 574 95 CI 531616 ini  542 vaccine recipient reported better experience Across stages pharmacy student positive attitude acceptability feasibility sustainability CARD reported high fidelity CARDrecommended interventions CARD recommended universitybased vaccination clinic improve vaccine recipient provider experiences",
        "mesh_terms": [
            "Humans",
            "Female",
            "Male",
            "Universities",
            "COVID-19",
            "Adult",
            "COVID-19 Vaccines",
            "Students, Pharmacy",
            "Vaccination",
            "SARS-CoV-2",
            "Middle Aged",
            "Surveys and Questionnaires",
            "Mass Vaccination",
            "Influenza Vaccines",
            "Young Adult",
            "Cohort Studies"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40773168/",
        "source_type": "Global"
    },
    {
        "pmid": "40772820",
        "title": "Influenza strains in focus: global approaches to the diagnosis, treatment, and control of H1N1, H3N2, H7N9, and H9N2.",
        "abstract": "Influenza virus various strain significant risk global health influenza various strain caused various periodic outbreak pandemics delve review study history threat possessed four prominent strain influenza H1N1 H3N2 H7N9 H9N2 also examines recent notable outbreak posed influenza strains 2009 H1N1 pandemic originated swine spread worldwide rapidly outbreak highlighted gap preparation response global healthcare system strain H3N2 long history frequent outbreak distress public health health care sector due evolution ability adapt 2013 China novel strain identified high mortality rate potential humantohuman transmission remains concern public health Another strain H9N2 though less infectious monitored ability cause pandemic future distinct genetic makeup sporadic human infection cause worry review outline difference similarities importance vigilant surveillance effective treatment strategies preparedness measure mitigate future influenza outbreaks",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40772820/",
        "source_type": "Global"
    },
    {
        "pmid": "40772746",
        "title": "[Fever, tetraparesis and confusion - neurological phenomena in influenza].",
        "abstract": "case study present unusual course 40yearold patient clinical sign viral infection leading gastrointestinal symptoms short term developed progressive ascending sensorimotor tetraparesis autonomic symptom well qualitative disturbance consciousness need intensive medical care Imaging revealed transverse myelitis diffusion disorder splenium socalled CLOCC lesion diagnosis mild encephalopathy reversible splenial lesion MERS longitudinally extensive transverse myelitis LETM made influenza B infection diagnosed causative disease immunologically triggered pathogenesis Immunosuppressive therapy indicated",
        "mesh_terms": [
            "Humans",
            "Male",
            "Adult",
            "Quadriplegia",
            "Influenza, Human",
            "Diagnosis, Differential",
            "Confusion",
            "Myelitis, Transverse",
            "Magnetic Resonance Imaging",
            "Fever of Unknown Origin",
            "Corpus Callosum",
            "Influenza B virus",
            "Diffusion Magnetic Resonance Imaging"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40772746/",
        "source_type": "Global"
    },
    {
        "pmid": "40772686",
        "title": "A luminescent attenuated SARS-CoV-2 for the identification and validation of drug-resistant mutants.",
        "abstract": "emergence severe acute respiratory syndrome coronavirus 2 SARSCoV2 variant necessitated continuous updating vaccines contrast antiviral remained effective target conserved viral protein essential viral life cycle However several mutation SARSCoV2 may affect efficacy United States US Food Drug Administration FDAapproved antiviral recently identified Detecting drugresistant SARSCoV2 mutant investigating escape mechanisms critical guide selection effective antiviral therapies study constructed attenuated recombinant rSARSCoV2 lacking open reading frame ORF protein 3a 7b expressing nanoluciferase Nluc rSARSCoV2 Δ3a7bNluc facilitate tracking viral infection Using virus selected drugresistant mutant main viral protease Mpro inhibitor nirmatrelvir passaging Δ3a7bNluc 10 time presence increasing concentration nirmatrelvir virus population enhanced resistance selected identified two nonsynonymous mutation L50F R188G Mpro encoded nonstructural protein 5 NSP5 gene Using reverse genetics generated rSARSCoV2 Δ3a7bNluc containing identified L50F R188G mutations individually combination assessed contribution nirmatrelvir resistance result indicate mutation involved escaping nirmatrelvir Altogether result demonstrate feasibility using rSARSCoV2 Δ3a7bNluc variant identify validate mutation confer resistance FDAapproved antiviral drug without concern conducting gain function GoF experiment wildtype WT form SARSCoV2 Smallmolecule antiviral drug used treatment severe acute respiratory syndrome coronavirus 2 SARSCoV2 infections However drugresistant SARSCoV2 mutant currently United States Food Drug Administrationapproved Mpro targeting antiviral identified Information SARSCoV2 escape mutant mutation affecting antiviral activity licensed antiviral remains limited study developed nanoluciferase Nlucexpressing attenuated recombinant rSARSCoV2 lacking ORF 3a 7b protein Δ3a7bNluc identify nirmatrelvirresistant mutant without biosafety concern associated gainoffunction GoF research using wildtype WT SARSCoV2 Using Δ3a7bNluc selected variant reduced sensitivity nirmatrelvir validated generation rSARSCoV2 Δ3a7bNluc containing candidate L50F R188G mutation Mpro result demonstrate feasibility using rSARSCoV2 Δ3a7bNluc safely identify validate drugresistant mutant overcoming concern originating adaptation study using WT SARSCoV2",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40772686/",
        "source_type": "Global"
    },
    {
        "pmid": "40772137",
        "title": "A Case Report of Atypical Hemolytic Uremic Syndrome Presenting With Disseminated Intravascular Coagulation.",
        "abstract": "previously healthy sevenyearold boy presented clinical laboratory finding consistent atypical hemolytic uremic syndrome aHUS given thrombocytopenia microangiopathic hemolytic anemia MAHA acute kidney injury setting influenza A Notably also met diagnostic criterion disseminated intravascular coagulation DIC time presentation clinical finding including prolonged prothrombin time PT markedly elevated Ddimer low fibrinogen aHUS DIC share overlapping clinical features traditionally regarded distinct entities aHUS driven complement dysregulation DIC widespread activation coagulation cascade resulting microvascular thrombosis consumptive coagulopathy secondary fibrinolysis patient treated supportive care eculizumab terminal complement inhibitor leading rapid sustained clinical laboratory improvement without recurrence case highlight diagnostic therapeutic complexity concurrent aHUS DIC lends clinical support emerging hypothesis uncontrolled complement activation may contribute DIC underscore value early recognition complementdirected therapy atypical hemolytic uremic syndrome HUS",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40772137/",
        "source_type": "Global"
    },
    {
        "pmid": "40771963",
        "title": "Glycosylation of canine tetherin is essential for its antiviral activity against H3N2 canine influenza virus.",
        "abstract": "Tetherin interferoninducedexpressing transmembrane protein utilizes unique topology restrict release enveloped virus surface cell membrane Nlinked glycosylation play important role protein posttranslational modifications investigate role glycosylation antiviral activity canine tetherin potential glycosylation site predicted mutated effect glycosylation site mutation treatment glycosylation inhibitor ability canine tetherin restrict H3N2 canine influenza virus CIV replication examined Mutations glycosylation site canine tetherin N72A N99A N7299A lead change intracellular distribution weakened even lost antiviral activity H3N2 CIV Similarly subcellular localization tetherin tunicamycin treatment altered antiviral activity weakened Colocalization analysis revealed colocalization canine tetherin H3N2 CIV protein weakened condition impaired glycosylation result indicate canine tetherin maintains localization cell membrane glycosylation exerts antiviral activity study provides new insight antiviral mechanism host restriction factor offer theoretical basis developing smallmolecule antiinfluenza strategy targeting glycosylation modifications",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40771963/",
        "source_type": "Global"
    },
    {
        "pmid": "40771611",
        "title": "AVIAN INFLUENZA VIRUS: THE NEXT PANDEMIC?",
        "abstract": "Novel avian influenza virus continue circulate animal specie around world show propensity reassort acquire virulence factors raise concern virus may adapt humans Pandemic preparedness relied heavily vaccine stockpiles However avian influenza strain genetically drift time stockpiled vaccine often fail elicit protective immunity genetic variants Various strategy help overcome immune imprinting immunological hyporeactivity well broaden immune response variant viruses Adjuvants remain key strategy improving immunological response avian influenza antigens Today three vaccine approved United States H5N1 influenza virus though continued focus surveillance pandemic preparedness essential prepare possibility humantohuman spread highly pathogenic influenza virus",
        "mesh_terms": [
            "Animals",
            "Humans",
            "Birds",
            "Influenza A Virus, H5N1 Subtype",
            "Influenza in Birds",
            "Influenza Vaccines",
            "Influenza, Human",
            "Pandemics"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40771611/",
        "source_type": "Global"
    },
    {
        "pmid": "40771428",
        "title": "Shu-Feng-Jie-Biao Formula Ameliorates Influenza A Virus-Induced Acute Lung Injury by Inhibiting NF-κB and ERK MAPK Signaling Pathways.",
        "abstract": "ShuFengJieBiao formula SFJBF used treat acute respiratory infection dozen years study aimed explore mechanism effect treatment influenza Network pharmacology used explore underlying mechanism SFJBF influenza protective effect SFJBF vivo evaluated lung indexes body weight loss pathological change lungs antiinflammatory effect vivo evaluated flow cytometry ELISA RAW2647 cell stimulated imiquimod R837 used determine antiinflammatory effect SFJBF Neutrophils isolated bone marrow activated phorbol 12myristate 13acetate PMA validate effect active component SFJBF SFJBF protected body weight loss decreased lung indexes reduced total protein content lung mitigated pathological change mice SFJBF inhibited expression chemokines iCxcl2i iCcl2i cytokine iIl1bi IL6 accompanied decreased infiltration neutrophil lungs SFJBF inhibited expression iNOS MPO lungs synergistic role OSV SFJBF exhibited suppressing virusinduced cytokine expression reducing infiltration inflammatory monocyte lungs SFJBF inhibited phosphorylation ERK12 NFκBp65 thereby reducing secretion MIP2 TNFα MCP1 CCL5 vitro active component SFJBF including baicalin wogonin reduced production reactive oxygen specie ROS MIP2 MCP1 IL6 vitro SFJBF ameliorated virusinduced lung injury suppressing overactivated immune response via NFκB ERK MAPK signaling pathways thereby protecting mouse influenza virus infection SFJBF could considered potent therapeutic agent treating influenza",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40771428/",
        "source_type": "Global"
    },
    {
        "pmid": "40771164",
        "title": "Repeated Annual Seasonal Influenza Vaccination of Patients With Circulatory Disease as Secondary Prevention of Cardiovascular Events: an Additional Self-Controlled Case Series Analysis.",
        "abstract": "Aim assess effect annual seasonal flu vaccination 3 year risk acute respiratory infection ARI cardiovascular event CVE cardiological patient followed using two analytical methodsMaterial method prospective comparative study included 817 patient October 2012 CVE chronic noncommunicable diseases ARI recorded October 2012 November 2015 analyzed Vaccinated unvaccinated patient compared using survival curve selfcontrolled case series method paired 6month periods Differences considered statistically significant plt005Results analysis included 813 patient mean age 633±116 years 405 men 201213201314201415 season 454441 patients respectively vaccinated 1 2 3 vaccination received 60 57 285 patients respectively 413 unvaccinated Compared unvaccinated patients patient vaccinated three time developed first ARI later plt00001 relative risk developing cardiovascular complication CVC 088 95 confidence interval 065110 Among vaccinated patients fewer patient ARI plt0001 cardiovascular disease p002 summer compared winter also summer ARI developed 412 fewer patient unvaccinated p0002Conclusion use two analytical method allowed u identify additionally nonspecific persistent specific effect threeyear flu immunization cardiological patient summer need confirmed randomized placebocontrolled studies",
        "mesh_terms": [
            "Humans",
            "Male",
            "Female",
            "Influenza Vaccines",
            "Middle Aged",
            "Cardiovascular Diseases",
            "Influenza, Human",
            "Secondary Prevention",
            "Vaccination",
            "Seasons",
            "Prospective Studies",
            "Aged",
            "Russia"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40771164/",
        "source_type": "Global"
    },
    {
        "pmid": "40771119",
        "title": "Impact of the 2018 Western Japan Heavy Rain Disaster on Anti-influenza Virus Drug Prescribing: A Longitudinal Analysis Using the National Health Insurance Claims Database.",
        "abstract": "study evaluated relationship heavy rain disaster influenza comparing victim nonvictims investigated association 2018 western Japan heavy rain disaster influenza patient registered National Health Insurance Claims Database treated Hiroshima Okayama Ehime prefecture included retrospective cohort study conducted 1year postdisaster multivariate mixedeffects logistic regression analysis used assess association disaster antiinfluenza drug prescribing differenceindifferences analysis conducted assess antiinfluenza drug use 4month period immediately every 4 month year postdisaster study included 6 176 300 individual victims 36 076 060 2573 71 458 157 74 victim nonvictim groups respectively used antiinfluenza drug year following flood victim significantly likely nonvictims use antiinfluenza drug risk ratio 118 95 confidence interval CI 112142 victim used significantly antiinfluenza drug 4 month immediately postdisaster compared disaster odds ratio 362 95 CI 177741 Antiinfluenza drug use higher among victim 2018 Western Japan heavy rain disaster among nonvictims",
        "mesh_terms": [
            "Humans",
            "Japan",
            "Male",
            "Female",
            "Retrospective Studies",
            "Antiviral Agents",
            "Middle Aged",
            "Adult",
            "Influenza, Human",
            "Longitudinal Studies",
            "Aged",
            "Databases, Factual",
            "Drug Prescriptions",
            "National Health Programs",
            "Cohort Studies",
            "Logistic Models",
            "Child",
            "Adolescent",
            "Disasters"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40771119/",
        "source_type": "Global"
    },
    {
        "pmid": "40770623",
        "title": "The epidemiology of infectious meningitis in Ghana: a systematic review and meta-analysis.",
        "abstract": "Meningitis significant health concern associated high fatality rates particularly resourcelimited setting Ghana whose northern region lie within African Meningitis Belt Despite plethora primary research data meningitis Ghana systematic review provides comprehensive information guide prevention control management effort yet undertaken systematic review therefore aimed bridging gap describing epidemiology meningitis Ghana including prevalence aetiology antimicrobial resistance comprehensive review electronic databases including PubMed Scopus conducted 2nd 4th December 2023 following established PRISMA guidelines search encompassed article published 1975 2023 age limitation study participants data extraction performed peerreviewed journal article reporting primary findings Studies exclusively reported meningitis animal models vitro vivo excluded Studies sample size less ten excluded analysis metaanalysis carried determine pooled estimate meningitis prevalence country 71205 suspected meningitis case analysed study period 3865 confirmed pooled overall prevalence 1813 Specifically case occurred nonoutbreak outbreak period pooled prevalence 1622 2391 respectively case fatality rate ranged 20 47 1998 2015 082 286 2016 2021 three northern region  Upper East 3085435 Northern 163464 Upper West 1796388  relatively high meningitis prevalence Greater Accra Ashanti Regions prevalence ranging 08 329 Streptococcus pneumoniae Neisseria meningitidis Haemophilus influenzae predominant isolates accounting 048777 25695 090340 cases respectively bacterial isolates meningitis case susceptible ceftriaxone common Neisseria meningitidis serogroups W135 A Y X Serotype 1 dominated among Streptococcus pneumoniae serotypes disparity distribution meningitis Ghana highest prevalence occurring northern part country seems reduction case fatality rate years probably due intervention vaccinations Ceftriaxone continues suitable treatment option meningitis continuous surveillance meningitis aetiological agent  especially serotyping common pathogen  help guide national vaccination policy programmes",
        "mesh_terms": [
            "Ghana",
            "Humans",
            "Prevalence",
            "Meningitis, Bacterial"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40770623/",
        "source_type": "Global"
    },
    {
        "pmid": "40770596",
        "title": "Influenza vaccination uptake of health care workers in a tertiary hospital: Findings from qualitative research in Mysuru, India.",
        "abstract": "Vaccinating health care worker HCWs common way prevent influenzarelated infection transmission patient absenteeism HCWs India influenza contributes 130000 death per year yet vaccination uptake HCWs low Fifteen percent HCWs received one vaccination 5 years study explored social context influenza vaccine uptake among HCWs including physicians nurse medical student teaching hospital Mysuru South India generate insight inform influenza vaccination campaign targeting HCWs Qualitative methods including indepth interview HCWs structured observation various department hospital applied result indicate influenza vaccination uptake among HCWs low due personal factor related little perceived personal threat emphasis prevention technique avoid transmission cost vaccine needle anxiety Besides institutional factors absence recommendation superior lack promotion campaign contribute low uptake conclusion HCW vaccination education promotion regarding diminishing personal transmission risk influenza virus uniform vaccination guideline strategy improve access including burdened cost vaccine suggested",
        "mesh_terms": [
            "Humans",
            "India",
            "Influenza, Human",
            "Influenza Vaccines",
            "Qualitative Research",
            "Tertiary Care Centers",
            "Female",
            "Male",
            "Adult",
            "Health Personnel",
            "Vaccination",
            "Interviews as Topic",
            "Attitude of Health Personnel",
            "Middle Aged"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40770596/",
        "source_type": "Global"
    },
    {
        "pmid": "40770014",
        "title": "Top 10 drugs most frequently associated with adverse events of myocarditis and pericarditis.",
        "abstract": "Myocarditis pericarditis managed various treatments yet prior study case report indicate certain drug class may elevate risk inflammatory cardiac conditions research aimed systematically identify leading drug frequently associated myocarditis pericarditis cases Analyses carried using global database individual case safety report 1968 2024 identified drug frequently reported signal detection myocarditis pericarditis selecting top 10 drug based record count excluding used treatment inflammatory cardiac condition avoid potential confounding Two statistical indicators information component IC ICsub025sub reporting odds ratio ROR 95 confidence interval CI used conduct disproportionality analysis study following five drug consistently observed myocarditis pericarditis clozapine mesalazine smallpox vaccine influenza vaccine COVID19 mRNA vaccine leading drug differed condition nivolumab pembrolizumab ipilimumab valproate metronidazole appearing frequently myocarditis ribavirin sulfasalazine methotrexate omalizumab heparin pericarditis drug showed significant signal detection myocarditis ROR 8322 95 CI 81178533 IC 396 ICsub025sub 394 pericarditis 4216 41194316 366 364 Although finding allow causal inference finding highlight importance monitoring possible adverse carditis case prescribing drugs study encouraged investigate underlying mechanisms assess individual patient risk factors explore longterm impact associated myocarditis pericarditis relation drug",
        "mesh_terms": [
            "Myocarditis",
            "Humans",
            "Pericarditis",
            "Drug-Related Side Effects and Adverse Reactions",
            "Databases, Factual",
            "Male",
            "Adverse Drug Reaction Reporting Systems",
            "Female"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40770014/",
        "source_type": "Global"
    },
    {
        "pmid": "40769533",
        "title": "<i>Haemophilus influenzae</i> in bronchiectasis.",
        "abstract": "Bronchiectasis chronic respiratory disease characterised irreversible bronchial dilation persistent productive cough alternating period clinical stability exacerbations distorted airway impair mucus clearance making susceptible recurrent infection chronic inflammation iHaemophilus influenzaei common pathogen bronchiectasis according international registries employ several virulence mechanisms including adhesion intracellular invasionsurvival biofilm formation evasion antibiotic treatments establish infection mechanism allow iH influenzaei persist respiratory tract evade host immune defences Although role welldocumented airway diseases impact iH influenzaei bronchiectasis remains incompletely understood International guideline recommend eradication therapy iH influenzaei upon first isolation intervention advised iPseudomonas aeruginosai cases Longterm immunomodulatory treatment macrolides option patient bronchiectasis chronic iH influenzaei infection frequent exacerbations though carry risk promoting antibiotic resistance iPseudomonasienriched airway microbiome Studies indicate significant negative interaction iP aeruginosai iH influenzaei suggesting competitive relationship influence microbiome dynamic potentially affect clinical outcomes Currently insufficient evidence support vaccination nontypeable iH influenzaei chronic airway disease Despite frequent detection respiratory samples precise role iH influenzaei bronchiectasisrelated morbidity disease progression fully understood warrant investigation review examines impact iH influenzaei bronchiectasis pathophysiology progression comparing role chronic respiratory diseases",
        "mesh_terms": [
            "Humans",
            "Bronchiectasis",
            "Haemophilus influenzae",
            "Haemophilus Infections",
            "Anti-Bacterial Agents",
            "Host-Pathogen Interactions",
            "Lung",
            "Risk Factors",
            "Treatment Outcome",
            "Virulence"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40769533/",
        "source_type": "Global"
    },
    {
        "pmid": "40768948",
        "title": "Point-of-need one-pot multiplexed RT-LAMP test for detecting three common respiratory viruses in saliva.",
        "abstract": "Respiratory viral infection pose significant global public health challenge partly due difficulty rapidly accurately distinguishing virus similar symptom point care hindering timely appropriate treatment limiting effective infection control prevention efforts Here developed multiplexed noninvasive salivabased reverse transcription loopmediated isothermal amplification RTLAMP test enables simultaneous detection three common respiratory infections severe acute respiratory syndrome coronavirus 2 SARSCoV2 Influenza Flu respiratory syncytial virus RSV single reaction via specific probe monitored realtime machinelearningenabled compact analyzer result demonstrate multiplexed assay effectively detect three target RNAs high accuracy Further testing spiked saliva sample showed strong agreement reverse transcription polymerase chain reaction RTPCR assay area curve AUC value 082 093 096 RSV Influenza SARSCoV2 respectively enabling rapid detection respiratory infection easily collected saliva sample point care device presented offer practical efficient tool improving outcome helping prevent spread contagious diseases",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40768948/",
        "source_type": "Global"
    },
    {
        "pmid": "40766376",
        "title": "Immunomodulation of the Innate Host Response by Mesenchymal-Derived Versican during Influenza A Virus Infection.",
        "abstract": "Viral bacterial lung infection place significant burden public health Versican extracellular matrix ECM chondroitin sulfate proteoglycan coordinate innate immune response multiple experimental models Versicans potential immunomodulatory molecule make promising therapeutic target controlling hosts immune response lung infection However versicans contribution lung inflammation injury immune cell activity influenza virus IAV infection represents critical knowledge gap address central hypothesis mesenchymalderived versican proinflammatory enhances innate immune response IAV infection generated tamoxifeninducible mouse deficient mesenchymalderived versican B6 Col1a2CresupERTsupVcansuptm11Cwfsup Col1a2Vcansupsup report mesenchymalderived versican play critical role neutrophil monocyte dendritic cell migration lung airway early IAV infection Intriguingly mesenchymalderived versican deficiency substantial negative impact neutrophil emigration lungs found neutrophil less adhesive ECM Col1a2Vcansupsup mouse lung fibroblast mLFs significant decrease versican compared wildtype mLFs Additionally Col1a2Vcansupsup mLFs treated polyIC iin vitroi reduced cellassociated hyaluronan finding suggest fibroblastderived versican necessary adhesion lung fibroblast neutrophil transit lung interstitium airway pulmonary vasculature finding demonstrate mesenchymalderived versican key regulator early host immune response IAV",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40766376/",
        "source_type": "Global"
    },
    {
        "pmid": "40766360",
        "title": "Stabilization of H5 highly pathogenic avian influenza hemagglutinin improves vaccine-elicited neutralizing antibody responses.",
        "abstract": "Transmission highly pathogenic avian influenza H5 clade 2344b expanded recent year infect large population bird mammals heightening risk human pandemic Influenza virus adapted transmission bird animal tend less stable hemagglutinin HA seasonal influenza viruses enabling membrane fusion comparatively high pH levels Here combine five mutation within H5 HA dramatically increase melting temperature promote stable closure HA trimer Structural analysis cryoelectron microscopy revealed stabilizing mutation create several new hydrophobic interactions maintaining local HA structure found vaccinating mouse stabilized H5 HA immunogen resulted higher hemagglutination inhibition neutralization titer nonstabilized comparators Epitope mapping vaccineelicited polyclonal antibody response using negative stain electron microscopy deep mutational scanning showed site E side HA receptor binding domain immunodominant across groups however stabilized immunogen shifted response toward receptor binding site RBS eliciting higher proportion neutralizing antibodies finding highlight H5 HAstabilizing mutation enhance quality antibody response across different vaccine formats underscoring potential improve pandemic preparedness vaccine targeting virus widely circulating clade",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40766360/",
        "source_type": "Global"
    },
    {
        "pmid": "40764862",
        "title": "Recent updates regarding the management and treatment of pneumonia in pediatric patients: a comprehensive review.",
        "abstract": "Pneumonia remains one leading cause illness death among children particularly low middleincome countries review present comprehensive update pediatric pneumonia covering recent advance etiology clinical presentation diagnostic tools treatment strategies prevention efforts explore traditional emerging diagnostic methods including use biomarkers like Creactive protein procalcitonin molecular testing pointofcare lung ultrasound Treatment approach discussed detail focus appropriate antibiotic use antiviral antifungal therapies supportive care oxygen therapy fluid management newer intervention like highflow nasal cannula therapy Preventive measures including introduction global rollout pneumococcal influenza RSV vaccines also emphasized addition review highlight ongoing challenge antimicrobial resistance healthcare disparities limited accessibility advanced diagnostic tool resourcepoor settings Finally outline research gap stress need strong public health policies global collaboration continued innovation reduce burden pediatric pneumonia improve outcome child worldwide Highlights Pediatric pneumonia continues cause high morbidity mortality especially low middleincome countries Advances diagnostics including lung ultrasound procalcitonin testing molecular tools improved early detection Rational antibiotic use stewardship program vital addressing rising antimicrobial resistance New preventive tools pneumococcal influenza RSV vaccines play key role reducing disease burden Health disparity limited access care remain major challenges highlighting need policy reform global health initiatives",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40764862/",
        "source_type": "Global"
    },
    {
        "pmid": "40764767",
        "title": "Characteristics of children with influenza admitted to a pediatric hospital in Greece during the 2022/2023 and 2023/2024 seasons.",
        "abstract": "Influenza result high morbidity mortality globally year Data pediatric influenza Greece COVID19 pandemic lacking study aim evaluate characteristic outpatient hospitalized pediatric influenza case post COVID19 pandemic Greece retrospective observational study conducted Children 016 year old laboratoryconfirmed influenza presented emergency department childrens hospital 20222023 20232024 influenza season studied total 976 child mean age 7 years male 539 enrolled 48 history influenza vaccination Compared unvaccinated children vaccinated patient comorbidities 298 vs 33 p  0001 highrisk contact 43 vs 07 p  0014 total 223 child 228 hospitalized significantly younger outpatient mean age 57 vs 74 years p  0001 Younger age presence comorbidities symptom vomiting myositis respiratory distress significantly associated hospitalization p  0001 Vaccination reduce risk hospitalization OR 070 95CI 030163 p  0405 Hospitalized child frequently experienced complication 480 vs 167 received antibiotic 342 vs 144 oseltamivir 789 vs 419 p  0001 Main complication among hospitalized patient included myositis 125 acute otitis medium 121 febrile seizure 89 pneumonia 85 Two unvaccinated child comorbidities admitted PICU one died due acute necrotizing encephalopathy Hospitalized child influenza presented serious complications Although 13 comorbidities nearly half experienced complication hospitalization recently introduced universal immunization child  5 year old Greece expected reduce influenza morbidity population •Influenza acute respiratory viral infection significant impact public health representing major cause morbidity mortality worldwide •To date published data child influenza Greece postCOVID19 era •This study highlight burden influenzaassociated ED visit hospitalization Greece particularly among younger child comorbidities •While influenza vaccination decrease risk hospitalization cohort likely attributed low vaccination rate higher prevalence comorbidities vaccinated group",
        "mesh_terms": [
            "Humans",
            "Greece",
            "Influenza, Human",
            "Child",
            "Male",
            "Female",
            "Child, Preschool",
            "Retrospective Studies",
            "Infant",
            "Adolescent",
            "Hospitalization",
            "COVID-19",
            "Hospitals, Pediatric",
            "Seasons",
            "Influenza Vaccines",
            "Infant, Newborn",
            "Vaccination",
            "Comorbidity"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40764767/",
        "source_type": "Global"
    },
    {
        "pmid": "40764589",
        "title": "Influenza B-associated acute myositis in a child in Sri Lanka: a case report.",
        "abstract": "Myositis characterized inflammation weakness skeletal muscles multifactorial condition caused various infectious autoimmune neuromuscular disorders Among these infective myositis rare significant clinical entity predominantly caused viral pathogens Viruses influenza enteroviruses rubella human immunodeficiency virus common culprits influenzaassociated myositis particularly welldocumented phenomenon Despite selflimiting nature many cases influenzaassociated myositis warrant clinical attention owing potential complication diagnostic challenge presents Influenza B less antigenically variable subtype compared influenza A increasingly recognized cause acute myositis especially pediatric populations report case 9yearold Sri Lankan girl central Sri Lanka presented 4day history fever cough cold followed bilateral calf pain difficulty walking examination exhibited bilateral calf tenderness normal muscle tone power reflexes without sensory impairment Basic hematological investigation within normal limits creatine kinase level markedly elevated 8370 UL indicating significant muscle damage Ultrasound imaging revealed inflammation calf muscles nasopharyngeal swab tested positive influenza B RNA confirming viral etiology Supportive care resulted complete symptom resolution within 10 day hospital discharge Influenzaassociated myositis important differential diagnosis child presenting muscle pain gait disturbance influenza season Early recognition laboratory confirmation condition prevent unnecessary investigation facilitate prompt patient management case highlight clinical diagnostic aspect influenza Bassociated myositis underscoring importance considering viral etiology pediatric patient acute myositis",
        "mesh_terms": [
            "Humans",
            "Child",
            "Influenza, Human",
            "Myositis",
            "Female",
            "Sri Lanka",
            "Influenza B virus",
            "Acute Disease",
            "Diagnosis, Differential",
            "Treatment Outcome"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40764589/",
        "source_type": "Global"
    },
    {
        "pmid": "40764134",
        "title": "[Clinical analysis of thirteen cases of pulmonary infection caused by <i>Nocardia otitidiscaviarum</i>].",
        "abstract": "bObjectiveb explore clinical characteristic patient pulmonary nocardiosis caused iNocardia otitidiscaviarumi enhance understanding disease bMethodsb retrospective analysis conducted clinical imaging pathogenic data 13 patient diagnosed pulmonary infection caused iNocardia otitidiscaviarumi Binzhou Peoples Hospital January 2022 December 2024 bResultsb patients age ranged 42 89 69±13 years 8 female 4 smoking history 5 male 3 smoking history clinical symptom included cough sputum production 8 patient including 1 dry cough fever 8 patients wheezing chest tightness 6 patients hemoptysis 3 patients Computed tomography CT scan chest showed 11 patient involvement lower lobe left lung 6 bilateral lung involvement 5 presented involvement upper lobe right lung 4 showed change middle lower lobe right lung 2 involvement upper lobe left lung imaging findings 8 patient exhibited consolidation shadows 5 displayed nodule shadows 4 necrotic cavity with 3 located lower lobe left lung Additionally 3 patient diagnosed bronchiectasis 1 necrotic lymph node 5 pleural effusion Microbial study result showed concomitant Aspergillus 3 cases iKlebsiella pneumoniaei 1 COVID19 infection 3 influenza 1 influenza B 1 13 patient demonstrated improvement following treatment trimethoprimsulfamethoxazole tablets bConclusionsb iNocardia otitidiscaviarumi rare form pulmonary nocardiosis occur individual preserved immune system pathogen associated severe clinical manifestations Furthermore risk iNocardia otitidiscaviarumi infection may exacerbated presence COVID19 virus influenza virus B Monitoring patient Aspergillus infection particularly crucial condition deteriorate rapidly posing considerable danger Consequently patient present aforementioned risk factor exhibit specific imaging features prompt screening diagnosis using metagenomic nextgeneration sequencing mNGS essential",
        "mesh_terms": [
            "Humans",
            "Male",
            "Female",
            "Nocardia Infections",
            "Middle Aged",
            "Retrospective Studies",
            "Aged",
            "Adult",
            "Nocardia",
            "Aged, 80 and over",
            "Tomography, X-Ray Computed",
            "COVID-19",
            "Lung",
            "SARS-CoV-2"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40764134/",
        "source_type": "Global"
    },
    {
        "pmid": "40764073",
        "title": "Antimicrobial use for influenza-like illnesses in Nha Trang, Vietnam: a cross-sectional study.",
        "abstract": "study aimed investigate characteristic management influenzalike illness ILIs outpatient inpatient setting Vietnam crosssectional observational study conducted questionnaire survey 407 individual ILI symptom presented public community health centre paediatric ward public hospital city Nha Trang Khanh Hoa Province Vietnam December 2022 March 2023 applicable primary secondary outcome prespecified study explanatory study basic characteristic participant presented using descriptive statistics conducted multivariable logistic regression analysis examine factor associated prescription antibiotic outpatient ILIs total 198 outpatient 200 inpatient enrolled study inpatient child 5 year age experienced longer illness duration higher costs almost patient receiving antibiotics rate antimicrobial prescription ILIs 793 outpatient 995 inpatients median healthrelated quality life score participant aged ≥18 year illness 0796 IQR 06740922 Logistic regression analysis indicated negative association definite diagnosis viral infection rapid diagnostic test outpatient antibiotic prescription OR 020 p0006 study underscore widespread inappropriate antimicrobial use ILIs community Vietnam contributes avoidable economic health burden result study suggest implementing diagnostic tool may support antimicrobial stewardship efforts",
        "mesh_terms": [
            "Humans",
            "Vietnam",
            "Cross-Sectional Studies",
            "Male",
            "Female",
            "Child, Preschool",
            "Adult",
            "Child",
            "Middle Aged",
            "Adolescent",
            "Influenza, Human",
            "Anti-Bacterial Agents",
            "Infant",
            "Young Adult",
            "Aged",
            "Surveys and Questionnaires",
            "Outpatients",
            "Quality of Life",
            "Logistic Models"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40764073/",
        "source_type": "Global"
    },
    {
        "pmid": "40763878",
        "title": "Immunization and cardiovascular disease in Latin America. The CorVacc study: rationale and design.",
        "abstract": "determine rate vaccination influenza pneumococcal disease general population Americas healthy sick analyze factor influencing rates InterAmerican Vaccination Registry Influenza Pneumococcus CorVacc Study crosssectional survey general population enacted 19 Latin American countries total 34 question given consecutive patient aged 18 year older online survey data analyzed country region according seven clusters demographics socioeconomic educational level cardiometabolic profile cardiovascular interventions medical followup treatments COVID19 vaccination status study conducted Prevention Council InterAmerican Society Cardiology study provide insight impact influenza pneumococcus vaccination Latin American population barrier preventing immunization target actualized Hopefully help facilitate development targeted focused health prevention strategies",
        "mesh_terms": [
            "Humans",
            "Latin America",
            "Cross-Sectional Studies",
            "Influenza Vaccines",
            "Cardiovascular Diseases",
            "Pneumococcal Vaccines",
            "Influenza, Human",
            "Vaccination",
            "Adult",
            "Registries",
            "Pneumococcal Infections",
            "COVID-19",
            "Research Design",
            "Male"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40763878/",
        "source_type": "Global"
    },
    {
        "pmid": "40763596",
        "title": "Design and synthesis of norsesquiterpenoid-1,2,3-triazole derivatives and investigation of their anti-influenza virus activity.",
        "abstract": "Influenza highly contagious acute respiratory illness caused influenza virus continual emergence drugresistant viral strain created urgent need development novel antiinfluenza agents previous study identified series norsesquiterpenoids potent activity influenza virus isolated fermentation broth Streptomyces sp XM17an actinobacterial strain derived fresh panda feces Building findings synthesized core norsesquiterpene scaffold functionalized attaching various molecular fragment 123triazole linker containing heteroatoms utilizing click chemistry strategy approach aimed enhance antiviral potency structural diversification Among resulting compounds 14d demonstrated superior antiviral activity influenza virus along low 50  cytotoxic concentration Mechanistic study indicated compound 14d exerted antiviral effect later stage viral infection Notably inhibit neuraminidase activity Instead disrupted cellular nuclear factor kappa B signaling pathway suppressed virusinduced overexpression proinflammatory cytokines Collectively result highlight compound 14d promising lead candidate development novel therapeutic targeting influenza virus infection",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40763596/",
        "source_type": "Global"
    },
    {
        "pmid": "40760695",
        "title": "Healthcare workers' attitudes toward influenza vaccine prescriptions in China.",
        "abstract": "Vaccine prescription implemented applied China bolster promote vaccination campaign mitigate vaccine hesitancy study aim investigate current vaccine recommendation practice among healthcare worker HCWs China identify determinant influence willingness provide vaccination prescription informing intervention support implementation willingness practice crosssectional survey conducted among HCWs nationwide China July 3 July 10 2024 survey questionnaire distributed via link provided expertlistening platform 2024 World Influenza Conference representing diverse group across different healthcare institutions study used descriptive logistic regression analysis performed attitude toward providing influenza vaccination prescriptions Among 3140 responding HCWs 688 hospitalbased HCWs N  7781131 619 communitybased HCWs N  12432009 demonstrate willingness provide vaccine prescriptions HCWs history influenza vaccination adjusted odds ratio aOR  030 95 confidence interval CI 023039 P  0001 significantly inclined provide vaccine prescriptions Incentives including bonus reward aOR  184 95 CI 140243 P  0001 integration annualmonthly performance evaluation aOR  160 95 CI 120213 P  0001 enhanced willingness provide prescriptions term communication methods 634 HCWs N  1991 identified official public account promotion WeChat effective raising vaccination awareness significantly surpassing provide vaccine prescription 87 N  350 study emphasizes necessity evaluation vaccine prescription policy improve implementation among HCWs finding advocate tailored strategies including enhanced incentive mechanism hospital setting optimized digital engagement community health centers facilitate effective vaccine prescription practices",
        "mesh_terms": [
            "Humans",
            "Influenza Vaccines",
            "China",
            "Cross-Sectional Studies",
            "Attitude of Health Personnel",
            "Female",
            "Male",
            "Adult",
            "Influenza, Human",
            "Health Personnel",
            "Middle Aged",
            "Surveys and Questionnaires",
            "Vaccination"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40760695/",
        "source_type": "Global"
    },
    {
        "pmid": "40759412",
        "title": "Respiratory and Other Infections Following COVID.",
        "abstract": "One hypothesis respiratory syncytial virus RSV surge 2022 suppression immune response following SARSCoV2 infection objective compare risk subsequent RSV infection among child without SARSCoV2 infection conducted retrospective cohort study using electronic health record data 27 US health system analyzing child aged 5 year SARSCoV2 infection testcoded March July 2022 comparison group child a influenza infection b respiratory tract infection evidence SARSCoV2influenza infection primary secondary outcome RSV infection respiratory infection subsequent 15 180 days respectively applied inverse probability treatment weighting performed weighted logistic regression modeling primary secondary cohort consisted 18 767 114 414 child SARSCoV2 infection 6697 30 424 influenza infection respectively 46 697 another acute respiratory tract infection odds subsequent RSV lower SARSCoV2 group compared influenza group adjusted odds ratio aOR 073 95 CI 061086 compared group respiratory tract infection aOR 078 95 CI 07087 odds respiratory tract infection infection lower SARSCoV2 group influenza group aOR 062 95 CI 059064 aOR 067 95 CI 06507 respectively find increased risk RSV respiratory type infection within 6 month SARSCoV2 infection compared influenza respiratory illnesses",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40759412/",
        "source_type": "Global"
    },
    {
        "pmid": "40758871",
        "title": "Influenza A virus NS1 protein mimics oncogenic PI3K resulting in isoform specific cellular redistribution and activation.",
        "abstract": "nonstructural protein 1 NS1 influenza virus performs broad variety proviral activity infected cell primarily mediating evasion host innate immune response main viral interferon antagonist However several interaction whose biological relevance remains obscure ability NS1 bind activate class IA phosphoinositide 3kinases PI3Ks PI3Ks highly regulated lipid kinase act critical node multiple cell signaling network also important protooncogenes activation mediated NS1 binding specifically p85β subunit better understand consequence interaction developed bimolecular fluorescence complementation BiFC assay selectively track different PI3K heterodimers and using system found NS1 induces isoformspecific relocation activation different PI3K heterodimers found clinically relevant oncogenic mutation catalytic regulatory subunit PI3K could mimic effect caused NS1 partially rescue loss viral fitness recombinant virus encoding p85βbinding deficient NS1",
        "mesh_terms": [
            "Viral Nonstructural Proteins",
            "Humans",
            "Influenza A virus",
            "Phosphatidylinositol 3-Kinases",
            "HEK293 Cells",
            "Class Ia Phosphatidylinositol 3-Kinase",
            "Animals",
            "Signal Transduction",
            "Protein Binding"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40758871/",
        "source_type": "Global"
    },
    {
        "pmid": "40758746",
        "title": "Socioeconomic determinants of protective behaviors and contact patterns in the post-COVID-19 pandemic era: A cross-sectional study in Italy.",
        "abstract": "Socioeconomic inequality significantly influence infectious disease outcomes seen COVID19 pathway socioeconomic condition affect transmission dynamic remain unclear address this conducted survey representative Italian population stratified age gender geographical area city size employment status education level surveys final aim estimate difference contact protective behavior across various population strata crucial understanding transmission dynamics initial insight based survey indicate year pandemic began perceived impact COVID19 professional economic social psychological dimension vary across socioeconomic strata extending beyond epidemiological outcomes reinforces need approach systematically consider socioeconomic determinants context using generalized linear models identified association socioeconomic factor vaccination status COVID19 influenza well influence socioeconomic condition maskwearing social distancing Importantly also observed difference contact behavior based employment status education level show significant association finding highlight complex interplay socioeconomic demographic factor shaping protective behavior contact patterns Understanding dynamic contribute improvement epidemic model better guide public health effort atrisk groups",
        "mesh_terms": [
            "Humans",
            "COVID-19",
            "Italy",
            "Female",
            "Male",
            "Cross-Sectional Studies",
            "Socioeconomic Factors",
            "Adult",
            "Middle Aged",
            "Pandemics",
            "SARS-CoV-2",
            "Aged",
            "Young Adult",
            "Adolescent",
            "Influenza, Human",
            "Surveys and Questionnaires"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40758746/",
        "source_type": "Global"
    },
    {
        "pmid": "40758339",
        "title": "Influenza With and Without Oseltamivir Treatment and Neuropsychiatric Events Among Children and Adolescents.",
        "abstract": "Reports pediatric neuropsychiatric event influenza treatment oseltamivir prompted public concerns However whether oseltamivir influenza infection associated increased risk neuropsychiatric event remains unclear determine association influenza oseltamivir serious neuropsychiatric events retrospective cohort study conducted populationbased ambulatory setting 2016 2017 2019 2020 influenza seasons Followup began first day influenza season continued earliest occurrence outcome event loss enrollment death age 18 years end season study Children aged 5 17 year enrolled Tennessee Medicaid eligible inclusion Data analysis completed July 2023 March 2025 personday followup assigned 1 following 5 mutually exclusive exposure groups 1 untreated influenza 2 treated influenza 3 posttreatment period period oseltamivir completion end influenza period 4 influenza prophylaxis 5 exposure primary outcome neuropsychiatric event requiring hospitalization event identified using validated algorithm Poisson regression estimated incidence rate ratio IRRs accounting relevant covariates measured personday Sensitivity analysis examined robustness finding alternate exposure outcome definitions timevarying outcome risk negative control outcome unmeasured confounding Among 692 975 eligible children total 692 295 child median IQR age 11 714 years 503 female experienced 1230 serious neuropsychiatric event 898 neurologic 332 psychiatric 19 688 320 personweeks followup Among 151 401 influenza episodes 667 95 CI 665670 dispensed oseltamivir 601 95 CI 596606 among high risk influenza complications common event overall mood disorder 363 suicidal selfharm behavior 342 Compared untreated influenza event rate lower oseltamivirtreated influenza period IRR 053 95 CI 033088 posttreatment period IRR 042 95 CI 024074 Subanalyses suggest finding driven reduction neurologic event IRR 045 95 CI 025082 psychiatric event IRR 080 95 CI 034188 Sensitivity analysis suggest misclassification unmeasured confounding would explain findings cohort study oseltamivir treatment influenza episode associated reduced risk serious neuropsychiatric events finding support oseltamivir use prevention influenzarelated complications",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40758339/",
        "source_type": "Global"
    },
    {
        "pmid": "40757932",
        "title": "First results from the international paediatric bronchiectasis registry (Child-BEAR-Net Registry) describing multicountry variations in childhood bronchiectasis and its management: a multicentre, cross-sectional study.",
        "abstract": "Despite increasing recognition bronchiectasis worldwide multicountry data characterising bronchiectasis children aimed describe clinical features comparing intercountry regional variations describe index overall qualityofcare standard assessed international consensus statement child young people bronchiectasis ChildBEARNet international collaborative paediatric bronchiectasis network across several continents Using International Paediatric Bronchiectasis Registry data secondary tertiary hospital across eight countries conducted multicentre crosssectional cohort study patient registry younger 18 year diagnosed bronchiectasis Data grouped four geographical regions Australia South Africa GreeceItalySpain AlbaniaTürkiyeUkraine Patients cystic fibrosis history heart lung transplantation excluded assessed baseline clinical characteristics causes treatments qualityofcare indicators compared finding across regions Data analysed using descriptive statistic nonparametric test betweengroup comparisons June 1 2020 Feb 9 2024 408 patient enrolled median age diagnosis 6·0 year IQR 3·29·0 229 56 male 179 44 female patients common underlying cause postinfection 127 31 primary secondary immunodeficiency 79 19 known genetic disorder 55 13 Common comorbidities included asthma 70 17 otorhinolaryngeal disorder 58 14 congenital major airway malformation 51 13 previous 12 months 106 38 least three exacerbation 89 49 required hospitalisation least once 107 27 400 reported daily sputum Lung function normal 133 59 227 patient considerable betweengroup difference median forced vital capacity Z score ranged 0·12 0·95 0·65 Australia 1·54 3·39 0·04 South Africa found marked intergroup difference lower airway bacteria Haemophilus influenzae 56 70 80 patient Australia three 16 19 AlbaniaTürkiyeUkraine Pseudomonas aeruginosa eight 24 34 South Africa one 5 AlbaniaTürkiyeUkraine treatment longterm azithromycin 47 50 94 GreeceItalySpain 15 19 79 AlbaniaTürkiyeUkraine inhaled corticosteroid 48 61 AlbaniaTürkiyeUkraine 28 22 126 Australia radiographic marker cystic bronchiectasis 49 45 109 South Africa three 2 126 Australia p0·0001 qualityofcare standard markers recommended panel investigation done 6695 patients 78 47 167 saw paediatric physiotherapist previous 12 months study present first internationally derived paediatric registry data highlighting geographical variation cause lung function bacteriology treatment child young people bronchiectasis well need improve quality care None",
        "mesh_terms": [
            "Humans",
            "Bronchiectasis",
            "Cross-Sectional Studies",
            "Male",
            "Female",
            "Child",
            "Registries",
            "Child, Preschool",
            "Adolescent",
            "Infant",
            "Australia",
            "Quality of Health Care"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40757932/",
        "source_type": "Global"
    },
    {
        "pmid": "40757858",
        "title": "Trained ILCs confer adaptive immunity-independent protection against influenza.",
        "abstract": "Seasonal influenza cause 290000650000 death annually vaccination efficacy ranging 10 60 emergence drugresistant highly pathogenic avian influenza virus underscore urgent need novel protective strategies Epidemiological observation long suggested certain vaccines Bacillus CalmetteGuérin BCG provide protection diverse pathogen S BieringSørensen P Aaby N Lund et al Clin Infect Dis 6511831190 2017 httpsdoiorg101093cidcix525 ML Garly C L Martins C Balé et al Vaccine 2127822790 2003 httpsdoiorg101016s0264410x03001816 C A G Timmermann S BieringSørensen P Aaby et al Trop Med Int Health 2017331744 2015 httpsdoiorg101111tmi12614 cellular molecular mechanism underlying protection remain incompletely understood emerging research offer critical insight innate immune system modulation B Cirovic L C J de Bree L Groh et al Cell Host Microbe 28322334 2020 httpsdoiorg101016jchom202005014 L Kong S J C F M Moorlag A Lefkovith et al Cell Rep 37110028 2021 httpsdoiorg101016jcelrep2021110028 H Mohammadi N Sharafkandi M Hemmatzadeh et al J Cell Physiol 23345124529 2018 httpsdoiorg101002jcp26250 S J C F M Moorlag Y A RodriguezRosales J Gillard et al Cell Rep 33108387 2021 httpsdoiorg101016jcelrep2020108387 investigated whether trained innate immune system nonreplicating adenovirus could provide protection diverse influenza virus strains demonstrated replicationdefective human adenovirus effectively train innate immune system conferring protective immunity mouse multiple influenza virus strains including H1N1 H3N2 H5N2 H7N9 H9N2 addition bovine chimpanzee adenovirus also activate human innate lymphoid cell ILCs confer protection challenge influenza H3N2 virus mice Remarkably protection occurs complete absence influenzaspecific adaptive immune response influenza virusspecific hemagglutinationinhibiting antibodies neutralizing antibodies influenza nucleoproteinspecific CD8 cells Key protective mechanism include increased activation ILC1 ILC2 ILC3 populations enhanced expression interferonstimulated gene ISGs upregulation antiviral signaling pathways metabolic reprogramming ILC subsets Adoptive transfer experiment demonstrated trained ILCs sufficient protect influenza H1N1 infection ILCdeficient mice research establishes novel strategy enhancing innate antiviral immunity offering broadspectrum protection diverse influenza strains promising approach pandemic preparedness also emerging infectious diseases Training innate lymphoid cell nonreplicating adenoviral vector represents promising approach enhancing broadspectrum antiviral immunity complementing traditional vaccination strategiesIMPORTANCEThe finding represent potential gamechanger fighting influenza kill hundred thousand people worldwide year despite best vaccination efforts Current flu vaccine often provide limited protection must reformulated annually match circulating strains effectiveness varies dramatically year year scientist discovered something remarkable common adenovirus which typically cause mild coldlike symptoms essentially train immune systems first line defense recognize fight multiple type flu virus simultaneously protection work completely different mechanism traditional vaccinesit rely creating specific antibody flu proteins Instead treatment activates special immune cell called innate lymphoid cell ILCs act like bodys rapid response team trained cell provide broad protection various flu strains including dangerous bird flu variant could cause future pandemics significance lie potentially creating universal flu protection strategy could work unknown future flu strains offering hope better pandemic preparedness reducing seasonal flus devastating global impact",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40757858/",
        "source_type": "Global"
    },
    {
        "pmid": "40757817",
        "title": "Pharmacokinetics, safety, and tolerability of onradivir in participants with severe renal impairment and matched healthy control participants.",
        "abstract": "Onradivir influenza virus RNA polymerase basic protein 2 inhibitor currently development treatment influenza A Renal impairment influence drug absorption metabolism transport potentially altering pharmacokinetics PK onradivir study aimed provide guidance clinical dosing patient renal impairment evaluating impact renal impairment PK safety tolerability onradivir nonrandomized parallel singledose study Participants severe renal impairment estimated glomerular filtration rate 1529 mLmin along healthy participant ini  eight per group received single oral dose 600 mg onradivir participant exhibited good safety tolerability oral administration onradivir treatmentemergent adverse event limited mild moderate severity Compared participant normal renal function maximum plasma concentration iCisubmaxsub onradivir severe renal impairment similar however area plasma concentration time curve zero last quantifiable concentration AUCsub0itisub AUC zero infinity AUCsub0infsub slightly lower geometric mean ratio 90 confidence interval iCisubmaxsub AUCsub0itisub AUCsub0infsub 10135 638516086 7631 524711097 7656 510211490 respectively Severe renal impairment clinically meaningful effect PK tolerability safety onradivir Therefore dose adjustment necessary patient mildtosevere renal impairment taking onradivirCLINICAL TRIALSThis study registered ClinicalTrialsgov NCT06248567",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40757817/",
        "source_type": "Global"
    },
    {
        "pmid": "40757797",
        "title": "Influenza Vaccination Among Patients Undergoing Treatment for Rheumatological Disorders: Awareness, Vaccination Rates, and Influencing Factors.",
        "abstract": "BackgroundAims Patients autoimmune inflammatory rheumatic disease AIIRDs particularly vulnerable infection result underlying autoimmune conditions vulnerability exacerbated immunosuppressive treatment associated comorbidities study aim evaluate influenza vaccination rates hesitancy awareness among patient population Materials Methods descriptive study included patient AIIRD receiving treatment rheumatology pulmonary medicine outpatient clinics January April 2024 questionnaire administered assess influenza vaccination rates knowledge attitudes Results patients 343 received least 1 influenza vaccination 13 vaccinated annually Additionally 622 recognized risk influenza infection due current illness medication believed vaccinated However 592 received professional information influenza vaccine 382 aware vaccination available free charge condition Older age prolonged medication use extended duration since diagnosis presence comorbidities awareness influenza risk receiving information vaccination significantly associated received least 1 influenza vaccination statistical relationship observed type rheumatic disease vaccination P 7803 Patients relying social media TV internet source demonstrated greater vaccine hesitancy P  0001 Awareness vaccination recommendation significantly associated medication type P  0001 Hesitancy reported 387 patient 48 unvaccinated patients influenced negative experience COVID19 vaccination process Conclusion Influenza vaccination coverage among patient AIIRD remains suboptimal Physician reminder routine visit could enhance vaccination rates Health authority might consider implementing popup alert clinical system prompt physician recommend vaccination prescribing immunosuppressive medications",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40757797/",
        "source_type": "Global"
    },
    {
        "pmid": "40757726",
        "title": "Influenza Virus-Associated Acute Necrotizing Encephalopathy in Two Young Children: Case Report.",
        "abstract": "bBackground Clinical Significanceb Acute necrotizing encephalopathy ANE represents severe complication mainly described children influenza virus infection report case two young girl ANE associated influenza virus infection diagnosed MRI cerebral scan bCase Presentationb 7yearold girl history previous episode ANE presented worsening drowsy state seizures second case otherwise healthy 5yearold girl presented fever seizures marked neurological deterioration cases nasopharyngeal swab testing positive influenza virus A cerebral MRI indicated ANE Despite aggressive treatment highdose corticosteroid fiveday course ofimmunoglobulins ultimate prognosis poor patients ANE serious complication viral infection children high mortality rate broad spectrum neurological sequelae date pathophysiology management influenza virusinduced ANE remain uncertain Although ANE usually sporadic familial recurrent case reported anRANbinding protein RANBP2 mutation occasionally associated occurrenceConclusions Rapid recognition neurological symptom suspicion viral trigger especially influenzalike illnesses essential timely administration effective therapy research needed clarify pathophysiology ANE establish best therapeutic strategy fight deadly disease",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40757726/",
        "source_type": "Global"
    },
    {
        "pmid": "40757690",
        "title": "Systemic Coagulation Derangement as an Early Sign of Oxygenator Failure in Veno-Venous Extracorporeal Membrane Oxygenation (VV ECMO) Without Anticoagulation.",
        "abstract": "bBackground Clinical Significanceb Venovenous extracorporeal membrane oxygenation VV ECMO become widely accepted supportive treatment severe acute respiratory distress syndrome ARDS intensive care unit ICUs Although gained popularity aspects including optimal anticoagulation management best mean monitoring hemostasis remain unresolved Thrombosis bleeding still important complication ECMO bCase Presentationb 44yearold male patient underlying conditions diagnosed severe acute respiratory distress syndrome ARDS due AH1N1 influenza presented severe hypoxemia despite use mechanical ventilation neuromuscular blocking agent infusion prone position VV ECMO used coagulation stopped ECLS day 6 due severe pulmonary hemorrhage systemic hemostatic disorder found patient difficult differentiate disseminated intravascular coagulation DIC sepsisinduced coagulopathy SIC improved transiently circuit exchange resolved discontinuation ECMO patient discharged fully conscious cooperative apparent neurological deficit bConclusionsb Systemic hemostatic abnormality may precede oxygenator failure mimic DIC SIC Timely oxygenator exchange may therefore considered However highrisk procedure especially fully ECLSdependent patients",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40757690/",
        "source_type": "Global"
    },
    {
        "pmid": "40757669",
        "title": "Inhibition Effects of Patchouli Alcohol, Carvacrol, p-Cymene, Eucalyptol and Their Formulations Against Influenza Virus Pneumonia Through TLR4/NF-κB/NLRP3 Signaling Pathway.",
        "abstract": "kind drug mostly used historically treat epidemics aromatic botanical volatile oil active components study aim evaluate antiinfluenza viral pneumonia effect volatile monomer patchouli alcohol PA carvacrol CV pCymene PC eucalyptol EC formulation various aspect influenza virus APR834 H1N1 infection experiment vivo vitro carry indepth study antiinflammatory mechanisms study found four volatile monomer mentioned could exert antiviral effect suppressing pulmonary viral load lung index improving lung lesion mouse influenza pneumonia addition elevated level cytokine chemokines serum suppressed proportion Tlymphocytes peripheral blood altered antioxidative stress index improved whose mechanism action related antiinflammation possibly acting TollLike Receptor 4Nuclear FactorκBnucleotidebinding domain leucinerich repeat pyrin domaincontaining receptor 3 TLR4NFκBNLRP3 pathway study provides experimental basis volatile monomer formulation aromatic herb treating influenza virus pneumonia",
        "mesh_terms": [
            "Cymenes",
            "Animals",
            "Toll-Like Receptor 4",
            "NF-kappa B",
            "NLR Family, Pyrin Domain-Containing 3 Protein",
            "Signal Transduction",
            "Mice",
            "Monoterpenes",
            "Eucalyptol",
            "Influenza A Virus, H1N1 Subtype",
            "Antiviral Agents",
            "Humans",
            "Orthomyxoviridae Infections",
            "Cytokines",
            "Lung",
            "Mice, Inbred BALB C",
            "Madin Darby Canine Kidney Cells",
            "Sesquiterpenes"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40757669/",
        "source_type": "Global"
    },
    {
        "pmid": "40757214",
        "title": "Blastomycosis in a Renal Transplant Recipient: A Rare Encounter in Rural Appalachia.",
        "abstract": "Blastomycosis fungal infection caused iBlastomycesi species thermally dimorphic fungi endemic midwestern southcentral southeastern United States US Organ transplant patient risk infection due longterm immunosuppressive therapy present unique case blastomycosis renal transplant patient residing nonendemic region Appalachia 67yearold patient history tobacco use atrial fibrillation type 2 diabetes hyperlipidemia bilateral deceased donor kidney transplantation DDKT 2021 presented Charleston Area Medical Centers CAMC Charleston WV Emergency Department ED fever night sweats Initial workup revealed 394 °C temperature remaining vital sign normal Corona parainfluenza influenza metapneumovirus mycoplasma pneumonia RSV negative GI PCR panel negative C difficle yersinia campylobacter giardia vibrio norovirus salmonella rotavirus Chest Xray showed 21 × 16 cm nodular density left upper lobe LUL lobe White blood cell WBC count elevated 13000mcl leftsided shift Subsequent computed tomography CT chest without contrast demonstrated 27 × 21 cm LUL mass Urine iBlastomycesi antigen tested positive prompting initiation empiric therapy blastomycosis Aspergillus ruled initially Blastomycosis rare occurrence US annual incidence reported 1 2 case per 100000 transplant recipient predisposed acquiring blastomycosis remains infrequent occurrence transplant patient presenting persistent infectious symptoms blastomycosis rare etiology considered prevent severe complications",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40757214/",
        "source_type": "Global"
    },
    {
        "pmid": "40756213",
        "title": "Gut microbiota and viral respiratory infections: microbial alterations, immune modulation, and impact on disease severity: a narrative review.",
        "abstract": "Respiratory viral infection major public health concern accounting million infection annually contributing significantly global morbidity mortality Influenza respiratory syncytial virus RSV long recognized critical pathogens recent emergence severe acute respiratory syndrome coronavirus 2 SARSCoV2 led COVID19 pandemic virus typically affect upper lower respiratory tract cause broad spectrum clinical manifestations ranging mild symptom severe respiratory failure multiorgan dysfunction Gastrointestinal symptom also frequently reported suggesting potential link respiratory virus gut microbiota alterations connection highlight role gut microbiota disease pathophysiology narrative review summarizes current evidence gut microbiota change associated SARSCoV2 influenza RSV infections explores microbiotas role immune regulation host homeostasis discusses potential microbiotatargeted strategy prevention management acute respiratory syndromes",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40756213/",
        "source_type": "Global"
    },
    {
        "pmid": "40756197",
        "title": "Analysis and Impact of Infection Prevention Procedures in Long-Term Care Facilities.",
        "abstract": "Healthcareassociated infection HAIs significant healthcare complication major implication public health EUEEA 26 million new HAIs case occur annually causing significant burden economic costs Italy prevalence HAIs rising due factor like invasive devices antibiotic resistance poor infection control aim work evaluate effectiveness HAIs containment practice longterm care facility LTCF crosssectional study included eight LTCF inspected Prevention Technicians Local Health Authority Tuscany SouthEast LHATSE 2023 study evaluated noncompliance procedure legionellosis prevention cleaning disinfection laundry management management pans HAIs prevention healthcare tool disinfection hairdressing services Data analysed using descriptive statistic Mann Whitney test compare infection rate procedure compliance 2023 606 infection reported eight enrolled LTCF frequent infection COVID19 194 urinary tract infection 169 pharyngitis 156 influenzalike illness ILI 15 Laundry Procedure 3 LTCF compliant 5 not showing significant relationship influenza syndrome p  002 surgical site infection p  004 Cleaning Check procedure noncompliance linked higher fungal infection p  001 gastroenteritis p  004 Disinfection Health Tools procedure showed noncompliance correlated higher gastroenteritis p  004 conjunctivitis p  001 Gastrointestinal infection iClostridium difficilei linked noncompliance HAIs Procedures Routes p  004 Pans process p  004 cleanliness hairdressing service p  004 Herpes simplex Herpes zoster infection higher LTCF noncompliant hairdressing service room p  002 Two legionellosis case recorded LTCF reported noncompliance analytical procedure Legionellosis analysis showed significant correlation cleanliness procedure reduction fungal infections gastroenteritis ear infections Compliance laundry procedure linked ILI surgical site infections Noncompliance healthcare tool correlated higher rate gastroenteritis conjunctivitis highlighting need stronger practices data suggest effective prevention measure reduce HAIs though discrepancy implementation across facility call standardization continuous monitoring",
        "mesh_terms": [
            "Humans",
            "Cross-Sectional Studies",
            "Italy",
            "Infection Control",
            "Cross Infection",
            "Long-Term Care",
            "COVID-19",
            "Disinfection",
            "Guideline Adherence"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40756197/",
        "source_type": "Global"
    },
    {
        "pmid": "40756189",
        "title": "Vaccine hesitancy in healthcare workers during COVID-19 pandemic: Draw on experience.",
        "abstract": "present study aimed identify factor affect healthcare workers HCWs vaccine hesitancy subsequent change psychological wellbeing 800 employee 207 M 14 aged ≤ 25 145 aged 2635 381 aged 3655 260 aged  55 years recruited San Martino Hospital first month 2021 HCWs asked fill online survey assessing a demographics b contracted COVID19 infection c vaccination history against COVID19 influenza d expected change psychological wellbeing e vaccine hesitancy f factor leading decision vaccine Information Trust Information Seeking Fear Self Sense Responsibility found that vaccinated HCW year employment adherence influenza vaccine indirectly affected vaccine hesitancy effect mediated HCWs sense responsibility information trust Moreover information trust promoted positive change psychological wellbeing vaccine hesitancy negatively affected it present study consistently point crucial role trusting information sense responsibility vaccine hesitancy and consequently psychological wellbeing discus practical implication public health findings conclusions suggest shortterm longterm strategy improving vaccine adherence",
        "mesh_terms": [
            "Humans",
            "Adult",
            "Vaccination Hesitancy",
            "COVID-19",
            "Male",
            "Female",
            "Middle Aged",
            "Health Personnel",
            "COVID-19 Vaccines",
            "Influenza Vaccines",
            "Surveys and Questionnaires",
            "Trust",
            "SARS-CoV-2",
            "Vaccination",
            "Pandemics"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40756189/",
        "source_type": "Global"
    },
    {
        "pmid": "40755950",
        "title": "Bilateral Meckel's Cave Cephalocele Presenting as Cranial Nerve VI Palsy: A Case Report.",
        "abstract": "Meckels cave cephalocele also known petrous apex cephalocele PAC rare cystic lesion caused herniation cerebrospinal fluid Meckels cave Bilateral PACs exceptionally rare 21 reported cases PACs may present headache diplopia tinnitus cranial nerve palsy 74yearold male presented acute onset headache vision changes gait instability medical history included hypertension melanoma Examination revealed left cranial nerve VI palsy Initial imaging head CT CTA showed acute intracranial abnormality revealed moderate chronic sinusitis Magnetic resonance imaging demonstrated large bilateral Meckels cave cephaloceles prominent left mass effect inferior margin cavernous sinus Steroid treatment initiated suspected influenzaassociated cranial neuropathy Followup reveal immediate improvement However several week steroid treatment symptom improved significantly patient deferred surgical intervention case highlight rare presentation bilateral PACs cranial nerve VI palsy Although surgical intervention may definitive conservative treatment provide relief symptom select cases research needed guide optimal management strategies",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40755950/",
        "source_type": "Global"
    },
    {
        "pmid": "40755805",
        "title": "Analytical performance evaluation of a multiplex real-time RT-PCR kit for simultaneous detection of SARS-CoV-2, influenza A/B, and RSV.",
        "abstract": "Differentiating influenza respiratory syncytial virus RSV SARSCoV2 based clinical symptom alone challenging due overlap crosssectional study conducted September November 2023 evaluated analytic performance LabTurbo multiplex realtime reverse transcription polymerase chain reaction RTPCR kit simultaneous detection viruses Nasopharyngeal swab specimen tested using LabTurbo kit Cobas Liat SARSCoV2 influenza AB assay Cobas influenza AB RSV assays RNA standard serially diluted tested LabTurbo kit determine limit detection LOD crosssectional study involved analysis 350 nasopharyngeal swab samples included 250 positive case 50 case influenza A influenza B RSV along 100 case SARSCoV2 100 negative cases LabTurbo kit demonstrated 100 positive percent agreement negative percent agreement reference assay detecting SARSCoV2 influenza AB RSV LODs SARSCoV2 influenza A influenza B RSV 8333 3333 6667 8333 copiesmL respectively finding confirm diagnostic accuracy analytic performance LabTurbo multiplex realtime RTPCR kit detection SARSCoV2 influenza AB RSV simultaneously assay could substantially improve rapid identification differentiation pathogens thereby enabling timely appropriate treatment measure control spread cocirculating viruses",
        "mesh_terms": [
            "Humans",
            "Cross-Sectional Studies",
            "SARS-CoV-2",
            "Influenza, Human",
            "Respiratory Syncytial Virus Infections",
            "COVID-19",
            "Influenza A virus",
            "Influenza B virus",
            "Nasopharynx",
            "Multiplex Polymerase Chain Reaction",
            "Real-Time Polymerase Chain Reaction",
            "Respiratory Syncytial Virus, Human",
            "Sensitivity and Specificity",
            "Female",
            "Limit of Detection"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40755805/",
        "source_type": "Global"
    },
    {
        "pmid": "40755567",
        "title": "Tracheomalacia and Interstitial Pneumonia in a 95-Year-Old Woman With Undiagnosed Rheumatoid Arthritis: A Case Report.",
        "abstract": "case report describes 95yearold woman history cardiovascular gastrointestinal disease presented fever anorexia diagnosed influenza secondary bacterial pneumonia Despite antiviral antibiotic treatment respiratory condition worsened Detailed examination revealed characteristic joint deformities elevated rheumatoid factor anticyclic citrullinated peptide antibodies Imaging showed interstitial pneumonia paradoxical breathing elevation membranous portion trachea indicating tracheomalacia patient diagnosed previously unrecognized rheumatoid arthritis associated interstitial pneumonia tracheomalacia Immunosuppressive therapy prednisolone azathioprine improved condition case highlight importance thorough systemic evaluation elderly patient unexplained respiratory symptom need consider lateonset autoimmune diseases including rheumatoid arthritis differential diagnosis",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40755567/",
        "source_type": "Global"
    },
    {
        "pmid": "40755518",
        "title": "Nova Scotia Health Influenza Treatment Team: Virtual Care Pathway to Antiviral Treatment.",
        "abstract": "",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40755518/",
        "source_type": "Global"
    },
    {
        "pmid": "40754333",
        "title": "Multicentre, prospective, single-arm, non-controlled, open-label trial to evaluate the safety and efficacy of live attenuated influenza vaccine in paediatric patients with atopic dermatitis undergoing dupilumab therapy: a protocol.",
        "abstract": "Atopic dermatitis AD chronic inflammatory skin condition impairs quality life affected paediatric patient families Dupilumab antagonist shared alpha chain subunit cytokine interleukin4 interleukin13 revolutionised management moderatetosevere AD effectively targeting type 2 inflammation However live attenuated vaccines including live attenuated influenza vaccine LAIVs contraindicated dupilumab therapy owing limited safety data restriction pose challenge immunisation strategies particularly paediatric populations study aim evaluate safety efficacy LAIV paediatric patient AD undergoing dupilumab therapy multicentre prospective singlearm openlabel trial enrol 50 paediatric patient aged 218 year AD undergoing dupilumab treatment participant receive intranasal LAIV followed 25week observation period vaccination primary outcome proportion participant fourfold greater increase haemagglutination inhibition titre influenza strain AH1N1 AH3N2 B 4 week post vaccination secondary outcome include incidence influenza systemic local adverse events injection site reactions fever influenzalike symptom observed within 4 week vaccination Exploratory endpoint include evaluation immunosuppressive marker neutrophil counts lymphocyte subset serum immunoglobulin G levels Safety analysis assess frequency adverse event whereas efficacy analysis focus immunogenicity influenza incidence 25week followup period study aim provide critical safety immunogenicity data guide immunisation strategy biologically treated paediatric patient AD study complies principle Declaration Helsinki received ethic approval Institutional Review Board Chiba University Hospital specified clinical trial Informed consent assent obtained appropriate based participants ages finding disseminated peerreviewed journal scientific conference inform clinical vaccination strategy biologically treated populations jRCTs031240442",
        "mesh_terms": [
            "Humans",
            "Child",
            "Influenza Vaccines",
            "Dermatitis, Atopic",
            "Antibodies, Monoclonal, Humanized",
            "Prospective Studies",
            "Adolescent",
            "Child, Preschool",
            "Vaccines, Attenuated",
            "Influenza, Human",
            "Female",
            "Male",
            "Multicenter Studies as Topic",
            "Influenza A Virus, H1N1 Subtype"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40754333/",
        "source_type": "Global"
    },
    {
        "pmid": "40753167",
        "title": "Broad neuraminidase antibodies confer protection against seasonal and avian influenza viruses.",
        "abstract": "Neuraminidase NA critical target universal influenza vaccine therapeutic antibodies yet antigenic landscape remains incompletely understood identify two broadly crossprotective monoclonal antibodies CAVF6 CAVF34 influenzainfected individuals antibody inhibit NA enzymatic activity across multiple subtypes confer protection seasonal influenza female mouse models Importantly two antibody also neutralize emerging avian strains including recent bovine H5N1 H7N9 strains pandemic potential Structural study reveal antibody target conserved region NA active site via HCDR3 blocking sialic acid interaction Furthermore observe distinct occupancy two antibody N2 tetramer likely due difference binding affinity finding provide molecular insight NAtargeted immunity offer foundation developing broadly protective influenza vaccine therapeutics",
        "mesh_terms": [
            "Animals",
            "Neuraminidase",
            "Female",
            "Mice",
            "Antibodies, Viral",
            "Humans",
            "Influenza A Virus, H5N1 Subtype",
            "Influenza Vaccines",
            "Antibodies, Monoclonal",
            "Influenza in Birds",
            "Influenza A Virus, H7N9 Subtype",
            "Influenza, Human",
            "Orthomyxoviridae Infections",
            "Mice, Inbred BALB C",
            "Cross Protection",
            "Antibodies, Neutralizing",
            "Cattle"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40753167/",
        "source_type": "Global"
    },
    {
        "pmid": "40752148",
        "title": "When farmers' knowledge matters: Improving epidemiological understanding of Peste des petits ruminants in northern Nigeria.",
        "abstract": "Peste de petits ruminant PPR endemic disease sheep goat Nigeria represents major threat livelihood smallholders Understanding epidemiology disease management livestock farmer essential developing appropriate surveillance control programmes study aimed enhance knowledge PPR conducting largescale survey 52 village Plateau Bauchi Kano state northern part Nigeria approach involved holding focus group discussion farmers men women collect knowledge disease understand perspective management result showed farmer use several different term refer disease likely PPR term might also used refer disease caused infectious agents Farmers rarely call veterinary service prevent disease vaccination seldom practiced Disease control attempted using conventional treatments without veterinary supervision using traditional therapies limited poor implementation good farming practice biosecurity measures study increased understanding PPR management area limited public private veterinary services addition also fostered trust scientist communities paving way future participatory action research programmes",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40752148/",
        "source_type": "Global"
    },
    {
        "pmid": "40751875",
        "title": "Exploring the Therapeutic Landscape of Probiotics in Enteric and Respiratory Viral Infections.",
        "abstract": "recent times understanding human microbiome impact health disease undergone paradigm shift leading groundbreaking discovery field probiotics Probiotics live microorganism known conferring health benefit administered adequately garnered significant interest potential modulate immune systems response viral infection human animals emergence enteric respiratory virus significant global health threat prompted intensive research effort identify novel therapeutic strategies Traditional antiviral therapy often face challenge drug resistance limited efficacy adverse effects underscoring urgent need alternative approaches context probiotic emerged promising avenue prevention treatment viral infection due ability modulate host immune response enhance mucosal barrier function exert direct antiviral effects review aim provide comprehensive overview therapeutic landscape probiotic enteric respiratory viruses Based latest finding preclinical clinical studies explored mechanism underlying antiviral activity probiotic potential role mitigating viral infections Furthermore promising avenue harnessing probiotic adjunctive standalone intervention enteric respiratory viral infection discussed here",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40751875/",
        "source_type": "Global"
    },
    {
        "pmid": "40751465",
        "title": "Influenza Vaccination and Short-Term Risk of Stroke Among Elderly Patients With Chronic Comorbidities in a Population-Based Cohort Study.",
        "abstract": "protective effect influenza vaccination stroke risk inconclusive study aimed investigate impact influenza vaccination 1year risk stroke individual aged 60 year older COPD hypertension diabetes mellitus conducted retrospective cohort study four district Shanghai China August 2017 July 2019 Data collected various information system related chronic disease management cardiovascular reporting immunizations incidence stroke within 1 year compared vaccinated unvaccinated chronic disease patients Cox proportional hazard regression used calculate hazard ratio HRs Sensitivity analysis performed using Poisson regression model examine association influenza vaccination stroke incidence propensity score matching employed address confounding found influenza vaccination associated lower risk stroke two influenza seasons 20172018 adjusted HR 027 95 CI 010073 20182019 adjusted HR 046 95 CI 021102 result Poisson regression model RR 026 95 CI 010070 consistent obtained Cox model analysis reduction stroke risk associated influenza vaccination ranged 54 73 finding suggest influenza vaccination associated lower 1year risk stroke individual chronic illnesses compared vaccinated",
        "mesh_terms": [
            "Humans",
            "Male",
            "Female",
            "Aged",
            "Influenza Vaccines",
            "Retrospective Studies",
            "Stroke",
            "China",
            "Influenza, Human",
            "Middle Aged",
            "Vaccination",
            "Hypertension",
            "Comorbidity",
            "Incidence",
            "Risk Factors",
            "Chronic Disease",
            "Pulmonary Disease, Chronic Obstructive",
            "Diabetes Mellitus",
            "Proportional Hazards Models",
            "Aged, 80 and over",
            "Cohort Studies"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40751465/",
        "source_type": "Global"
    },
    {
        "pmid": "40750655",
        "title": "Methodic aspects of influenza and respiratory syncytial virus detection in raw wastewater and presence in treatment plants in southeastern Germany.",
        "abstract": "COVID19 pandemic wastewaterbased epidemiology WBE developed additional tool follow epidemiological trend catchment area treatment plants Meanwhile viral agent respiratory infection included monitoring programs However difference sample processing may impair result comparison among studies identical virus strains investigated different concentration methods RNA isolation kit primerprobe combination detection influenza virus IV AB respiratory syncytial virus RSV AB procedure optimization virus enrichment RNA extraction method found relevance Conversely detection step identified relatively low influence Using standardized protocols 24 h composite sample eight wastewater treatment plant WWTP southeast Germany 2xweek analyzed January 2024 December 2024 IVAB RSVAB following rate viruspositive sample determined 205 IVA including 22 H1N1pdm09 45 IVB 326 RSVA 24 RSVB IV RSV detection showed matching trend compared reported cases study contributes better understanding factor influencing detection IV RSV wastewater well epidemiological significance virus monitoring WWTPs",
        "mesh_terms": [
            "Germany",
            "Wastewater",
            "Humans",
            "RNA, Viral",
            "Influenza, Human",
            "Respiratory Syncytial Virus Infections",
            "Respiratory Syncytial Virus, Human",
            "COVID-19",
            "Respiratory Syncytial Viruses"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40750655/",
        "source_type": "Global"
    },
    {
        "pmid": "40750617",
        "title": "Structural convergence and water-mediated substrate mimicry enable broad neuraminidase inhibition by human antibodies.",
        "abstract": "Influenza responsible multiple global pandemic seasonal epidemic claimed million lives imminent threat panzootic outbreak avian influenza H5N1 virus underscore urgent need pandemic preparedness effective countermeasures including monoclonal antibody mAbs Here characterize human mAbs target highly conserved catalytic site viral neuraminidase NA termed NCS mAbs molecular basis broad specificity Crossreactive NAspecific B cell isolated using stabilized NA probe noncirculating subtypes found NCS mAbs recognized multiple NAs influenza well influenza B NAs conferred prophylactic protection mouse H1N1 H5N1 influenza B viruses Cryoelectron microscopy structure two NCS mAbs revealed rely structural mimicry sialic acid substrate NA coordinating amino acid side chain also water molecules enabling inhibition NA activity across multiple influenza B viruses including avian influenza clade 2344b H5N1 viruses result provide molecular basis broad reactivity inhibitory activity NCS mAbs targeting catalytic site NA substrate mimicry",
        "mesh_terms": [
            "Neuraminidase",
            "Humans",
            "Animals",
            "Antibodies, Monoclonal",
            "Influenza A Virus, H5N1 Subtype",
            "Mice",
            "Catalytic Domain",
            "Antibodies, Viral",
            "Cryoelectron Microscopy",
            "Molecular Mimicry",
            "Water",
            "Influenza, Human",
            "Influenza B virus",
            "Influenza A Virus, H1N1 Subtype",
            "Orthomyxoviridae Infections",
            "Viral Proteins",
            "Cross Reactions",
            "Female",
            "Mice, Inbred BALB C"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40750617/",
        "source_type": "Global"
    },
    {
        "pmid": "40750588",
        "title": "Structural basis of broad protection against influenza virus by human antibodies targeting the neuraminidase active site via a recurring motif in CDR H3.",
        "abstract": "Influenza virus evolve rapidly driving seasonal epidemic posing global pandemic threats neuraminidase NA emerged vaccine target shared molecular feature NA antibody response still well understood Here describe cryoelectron microscopy structure broadly protective human antibody DA03E17 previously identified H1N1infected donor complex NA AH1N1 AH3N2 BVictorialineage viruses DA03E17 target highly conserved NA active site using long CDR H3 feature DR AspArg motif engages catalytic residue mimic sialic acid interactions demonstrate motif conserved among several NA active sitetargeting antibodies indicating common receptor mimicry strategy also identified BCR sequence containing DR motif across donor healthy human repertoire database suggesting precursor may relatively common vaccine targeting potential finding reveal shared molecular feature NA active sitetargeting antibody harnessed design broad immunefocused influenza vaccines",
        "mesh_terms": [
            "Humans",
            "Neuraminidase",
            "Catalytic Domain",
            "Antibodies, Viral",
            "Complementarity Determining Regions",
            "Cryoelectron Microscopy",
            "Amino Acid Motifs",
            "Influenza, Human",
            "Influenza A Virus, H1N1 Subtype",
            "Influenza Vaccines",
            "Influenza A Virus, H3N2 Subtype",
            "Models, Molecular",
            "Viral Proteins"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40750588/",
        "source_type": "Global"
    },
    {
        "pmid": "40749991",
        "title": "Ubiquitin E3 ligase MARCH10 targets influenza hemagglutinin for ubiquitination.",
        "abstract": "Influenza virus infection damage airway cause acute lung injury Influenza virus infection remains difficult combat since treatment limited supportive care antiviral drug prevent influenza early condition Influenza hemagglutinin HA surface glycoprotein facilitates viral entry binding sialic acidcontaining receptor hosts lung cells Therefore promising target development antiinfluenza therapeutic drugs demonstrate understudied E3 ligase MARCH10 destabilizes influenza HA protein doseresponse manner decrease halflife influenza HA time However affect mRNA expression influenza HA Further MARCH10 specifically polyubiquitinates influenza HA targeting degradation BEAS2B cell ectopically expressed MARCH10 infected PR8 virus 1378 gene differentially expressed addition analysis reveals MARCH10 upregulates multiple pathway involved interferon signaling influenza virus infection finding suggest MARCH10 play protective role influenza virus infection may enhance airway host defense innate immunity",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40749991/",
        "source_type": "Global"
    },
    {
        "pmid": "40749838",
        "title": "Indications for corticosteroids in the treatment of Community-Acquired pneumonia.",
        "abstract": "Preceding guideline treatment management communityacquired pneumonia CAP endorse systematic use corticosteroids data literature show contradictory results suggested clinical improvement case severe CAP others reported significant benefit recent CAPECOD trial demonstrated marked reduction mortality intubation early hydrocortisone treatment 200 mgd Consequently 2025 French guideline recommend used case severe CAP requiring critical care excluding influenza myelosuppression aspiration pneumonia considered trial progressive deescalation course eight fourteen days Since benefit seen shown nonsevere CAP corticosteroid therapy recommended cases",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40749838/",
        "source_type": "Global"
    },
    {
        "pmid": "40749835",
        "title": "Value of molecular biology tests in community-acquired acute pneumonia.",
        "abstract": "patient hospitalized communityacquired acute pneumonia CAP molecular tool especially multiplex PCR syndromic panels associated significant improvement microbiological diagnosis yield compared conventional methods Two main family test currently available targeted viral PCR test influenza SARSCoV2 RSV performed nasopharyngeal swab adapted epidemic situations upper respiratory tract nasopharyngeal lower respiratory tract deep swabs syndromic panel detect broad spectrum viral bacterial agents sometimes including resistance genes test recommended routine use CAP patient treated ambulatory settings hospitalized CAP patients use must guided severity epidemic context therapeutic implications Upper respiratory tract panel useful atypical agent virus undetected targeted PCR test suspected Lower respiratory tract panel must used case severe form complex situations Clinical trial showed real diagnostic value variable clinical impact often limited absence optimization strategy antibiotic therapy Multiplex PCR syndromic panel represent promising step forward management patient hospitalized CAP clinical value still depends several factors type panel swab quick results presence mobile team infectious disease specialists capacity correctly interpret result guide treatment decisions",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40749835/",
        "source_type": "Global"
    },
    {
        "pmid": "40749819",
        "title": "A rapid CRISPR/Cas12a-based assay for the detection of HIV-1 Clade C in infants.",
        "abstract": "Early detection HIV1 infection essential initiating antiretroviral therapy ART suppress viremia prevent disease progression Timely diagnosis especially infants critical rapid antibodybased serology test ineffective due presence maternal antibodies developed CRISPRCas12abased HIV1 detection assay optimizing component coupled isothermal preamplification using recombinase polymerase amplification RPA assay targeted conserved region pol gene specific HIV1 designed CRISPR RNA crRNA CRISPRCas12amediated cleavage viral cDNA visualized collateral cleavage singlestranded DNAFAMBQ reporter enabling rapid visually detectable outcomes performance assay evaluated using plasma 41 HIV1 Clade C HIV1C seropositive individuals including 28 HIV1C infected infant samples HIV1 Indian Clade C Clade B genome plasmids viral disease control DNARNA sample Influenza RSV Parvovirus HPIV CMV HBV 31 healthy donor plasma samples Sensitivity specificity assessed detection performed using fluorescence visual readout lateral flow dipsticks CRISPRCas12abased HIV1 Clade C detection assay achieved sensitivity 96  specificity 9265  assay successfully provided result fluorescence visual readout compatible lateral flow dipstick formats facilitating easy rapid detection developed CRISPRCas12abased HIV1C detection assay demonstrates high sensitivity specificity Clade C indicating potential robust pointofcare molecular diagnostic tool HIV1C Additionally may serve rapid nucleic acid test alternative detecting mothertochild transmission HIV1C infant two year age traditional antibodybased test ineffective assay hold promise improving early HIV1 diagnosis timely initiation ART ultimately contributing better disease management outcomes",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40749819/",
        "source_type": "Global"
    },
    {
        "pmid": "40749064",
        "title": "A pan-respiratory virus attachment inhibitor with high potency in human airway models and in vivo.",
        "abstract": "Respiratory virus cause severe infections often leading hospitalization death pose major pandemic threat broadspectrum antiviral currently available However respiratory virus use sialic acid heparan sulfate attachment receptors Here report identification panrespiratory antiviral strategy based mimicking glycans synthesized modified cyclodextrin simultaneously mimic heparan sulfate sialic acid compound demonstrated broadspectrum antiviral activity important human pathogens parainfluenza virus 3 respiratory syncytial virus influenza virus H1N1 severe acute respiratory syndrome coronavirus 2 SARSCoV2 addition compound active avian strain influenza virus revealing importance pandemic preparedness compound retains broadspectrum activity ex vivo model respiratory tissue vivo respiratory syncytial virus influenza virus using prophylactic therapeutic strategies finding contribute development future treatment preventive measure respiratory viral infections",
        "mesh_terms": [
            "Humans",
            "Antiviral Agents",
            "Animals",
            "SARS-CoV-2",
            "Virus Attachment",
            "Influenza A Virus, H1N1 Subtype",
            "Parainfluenza Virus 3, Human",
            "Heparitin Sulfate",
            "Dogs",
            "Mice"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40749064/",
        "source_type": "Global"
    },
    {
        "pmid": "40748960",
        "title": "A bacteria-based search for drugs against avian and swine flu yields a potent and resistance-resilient channel blocker.",
        "abstract": "Influenza represents significant threat seasonal epidemic transition global pandemics crossspecies infection presenting continuous challenge vaccine several antiviral drug available constant genetic change vitiate prevention treatment options Consequently decided search inhibitor one viruss validated drug targets M2 channel blocked aminoadamantanes Regrettably widespread mutation M2 abolish antiflu activity said blockers Therefore devised bacteriabased genetic assay screen drug aminoadamantanesensitive resistant M2 channel map resistance potential identifiable blocker Subsequent cellulo testing structureactivity relationship study yielded synergistic combination two compounds Theobromine Arainosine exhibited remarkable antiviral activity directly inhibiting viruss channel drug duo potent H1N1 pandemic swine flu H5N1 pandemic avian flu aminoadamantaneresistant sensitive strain alike exhibiting activity surpassed oseltamivir leading antiflu drug market drug duo tested animal model outperformed oseltamivir considerably reducing disease symptom viral RNA progeny Importantly harnessing bacterial genetic selection could demonstrate drug duos potential eliciting drug resistance significantly smaller molecularly distinct aminoadamantanes conclusion outcome study represents new potential treatment option influenza alongside approach sufficiently general readily applicable viral targets",
        "mesh_terms": [
            "Antiviral Agents",
            "Animals",
            "Influenza A Virus, H1N1 Subtype",
            "Drug Resistance, Viral",
            "Humans",
            "Influenza A Virus, H5N1 Subtype",
            "Influenza, Human",
            "Swine",
            "Orthomyxoviridae Infections",
            "Mice",
            "Bacteria",
            "Dogs",
            "Influenza in Birds",
            "Birds",
            "Madin Darby Canine Kidney Cells",
            "Viroporin Proteins",
            "Viral Matrix Proteins"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40748960/",
        "source_type": "Global"
    },
    {
        "pmid": "40746816",
        "title": "False-Positive Detection of Haemophilus influenzae by a Multiplex PCR Panel in a Neonate With Late-Onset Group B Streptococcal Bacteremia.",
        "abstract": "Here report case term neonate lateonset Group B Streptococcal GBS bacteremia FilmArray® MeningitisEncephalitis ME panel BioFire Diagnostics Salt Lake City UT US falsely detected iHaemophilus influenzaei cerebrospinal fluid CSF Although CSF showed mild pleocytosis elevated protein clinical sign bacterial meningitis Confirmatory testing including multiplex PCR targeting iH influenzaei siaT GBS cfb 16S rRNA well CSF culture yielded negative results Repeat FilmArray testing controlled condition also negative manufacturers investigation revealed borderline amplification one iH influenzaei targets interpreted algorithmically positive discordance highlight key limitation multiplex PCR panels lack transparency signal interpretation threshold settings patient demonstrated immunodeficiency remained clinically stable 10month followup case underscore importance confirmatory testing panel result contradict clinical picture advocate improved algorithmic clarity interlaboratory validation Increased awareness diagnostic pitfall essential particularly neonatal setting unnecessary antimicrobial intervention may pose additional risks",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40746816/",
        "source_type": "Global"
    },
    {
        "pmid": "40746183",
        "title": "Nanchangmycin suppresses influenza A virus infection by blocking endosomal acidification.",
        "abstract": "Influenza virus IAVs constitute major threat human animal health Currently M2 ionchannel inhibitors neuraminidase NA inhibitors RNA polymerase inhibitors capdependent endonuclease inhibitor applied clinically therapeutic IAVs However IAVs possess adaptive mutation inhibitors especially M2 ion channel NA inhibitors Thus novel antiviral agent developed present study screen approximately 5500 compound identify IAV inhibitor nanchangmycin possesses robust antiviral activity iin vitroi iin vivoi addition exhibit broadspectrum antiviral activity additional virus infections including pseudorabies virus herpes virus porcine epidemic diarrhea virus porcine reproductive respiratory syndrome virus importantly antiviral activity oseltamivirresistant strain subμM range promotes survival MDCK cell infected oseltamivirresistant influenza virus strain study reveal block nucleus migration viral nuclear protein NPs resulting NP accumulation cytoplasm particularly within perinuclear endosomes Also inhibits IAVs blocking endosomal acidification Overall nanchangmycin potential developed antiinfluenza agent",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40746183/",
        "source_type": "Global"
    },
    {
        "pmid": "40746014",
        "title": "Yeast Beta-Glucan Enhances Antibody Response Following Influenza Vaccination - A Double-Blind, Randomized, Placebo-Controlled Pilot Trial.",
        "abstract": "Yeast betaglucans demonstrate immunemodulating effects however study explored potential yeast betaglucans enhance immune response vaccination pilot study aimed assess adjuvant effect yeast betaglucan supplementation antibody titer response influenza vaccination Adults ini  90 707 ± 101 years recruited two vaccination season randomized receive 500 mg betaglucan placebo 500 mg cellulose daily doubleblind study design Pre 4 wk postvaccination serum influenzaspecific antibody titer assessed using optimized Hemagglutination Inhibition HI assay Plasma cytokine 24 h postvaccination quantified immunoassay Cold flu symptoms using Modified Jackson Criteria fever selfperceived fatigue monitored daily Linear mixed model used test difference fixed effect time treatment interactions season 1 Fall 2022 despite baseline suggesting seroprotection Influenza H3N2 AWisconsin672005 92 betaglucan group 74 placebo group postvaccination antibody titer response Δ  958 favored betaglucan placebo ipi  0037 Influenza BAustria13594172021 antigen demonstrated poor detection 7 10 HI detectible antibody response seen betaglucan group season 2 Fall 2023 Influenza H1N1 AVictoria48972022 antigen demonstrated poor detection 14 precluded cohort analyses cytokines interferongamma IFNγ increased similarly group vaccination supporting adjuvant action betaglucan cellular level Reported cold flu symptom low group differ Overall finding suggest yeast betaglucan supplementation may elicit greater change antibody titer seasonal influenza vaccination However confirmation needed larger sample older adult followup assess protection disease Clinical trial registry number website httpsclinicaltrialsgovstudyNCT05074303",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40746014/",
        "source_type": "Global"
    },
    {
        "pmid": "40745568",
        "title": "High-fat diet impairs microbial metabolite production and aggravates influenza A infection.",
        "abstract": "Alterations gut microbiom significantly impact various region human body including pulmonary tract study investigates alteration gut microbiome highfat diet HFD particularly shortchain fatty acid SCFAs metabolite affect lung infection caused Influenza virus IAV used HFDmouse model evaluate gut microbiota composition SCFA levels pulmonary outcome following IAV infection Microbial change analyzed via taxonomic functional profiling SCFA level measured nonobese obese serum donors Ultimately acetates effect tested ex vivo human precisioncut lung slice PCLS vitro pulmonary epithelial cells Mechanistic study investigated involvement SCFA receptor free fatty acid receptor 2 FFAR2 intracellular antiviral pathways data indicates increased FirmicutesBacteroidetes ratio gut microbiome altered carbohydrate metabolism leading reduced SCFA production Infected HFD mouse showed increased IAV titer sustained microbial alterations Interestingly acetate demonstrated antiviral effect human PCLS model pulmonary cell reduced viral replication effect depended FFAR2 also act IAV coreceptor acetate treatment led FFAR2 internalization influenced host cell metabolism vitro data HFD alters SCFA production reducing acetate level gut microbiome reduction may lead higher viral load worsened disease HFD mouse infected IAV finding indicate acetate antiviral effect IAV infection human ex vivo lung model pulmonary epithelial cells Here acetate prevents viral entry affect cellular metabolic state antiviral response Understanding mechanism could provide new target preventing treating viral infection individual dietrelated health issues",
        "mesh_terms": [
            "Animals",
            "Diet, High-Fat",
            "Humans",
            "Influenza A virus",
            "Mice",
            "Fatty Acids, Volatile",
            "Gastrointestinal Microbiome",
            "Orthomyxoviridae Infections",
            "Mice, Inbred C57BL",
            "Male",
            "Influenza, Human",
            "Lung",
            "Acetates"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40745568/",
        "source_type": "Global"
    },
    {
        "pmid": "40745284",
        "title": "Burden of bacterial lower respiratory tract infections in hospitalized children and epidemiological characteristics of pathogens in Hanzhong, China (2023-2024).",
        "abstract": "analyse epidemiological characteristic bacterial lower respiratory tract infection LRTIs hospitalized child aged 014 year Hanzhong Central Hospital China provide evidence empirical treatment infection control retrospective analysis conducted bacterial detection excluding Mycoplasma pneumoniae Chlamydia pneumoniae seasonal variation gender distribution age distribution among RTI paediatric patient admitted Hanzhong Central Hospital January 2023 July 2024 Among 5463 respiratory specimen child clinically diagnosed lower respiratory tract infections 2093 bacterial strain isolated yielding culture positivity rate 3830 total 3413 specimen 6288 exhibited mixed growth normal respiratory flora classified culturenegative pathogenic bacteria based standard microbiological criteria identified bacterial pathogen included Haemophilus influenzae a recognized common cause respiratory tract infections well Staphylococcus aureus Klebsiella pneumoniae Escherichia coli typically associated severe hospitalacquired lower respiratory tract infection rather communityacquired cases Bacterial infection showed seasonal variation prevalent spring first quarter summer second quarter variation dominant bacterial strain across different quarters infection rate male child higher female quarters statistically significant difference observed particularly infection rate Staphylococcus aureus Klebsiella pneumoniae Children aged 03 year highest risk group Staphylococcus aureus infection 1161 detection rate various pathogen declined increasing age Staphylococcus aureus Haemophilus influenzae identified predominant pathogen responsible paediatric respiratory infection Hanzhong exhibiting peak prevalence spring summer greatest burden among child 3 year age marked male predominance agespecific pathogen distribution pattern highlight necessity seasonal surveillance agetailored empiric treatment strategies strengthened infection control measure childcare environments finding offer evidencebased insight inform clinical management public health intervention northwest China family caregiver healthcare provider remain vigilant epidemiological characteristic diagnosis prevention treatment",
        "mesh_terms": [
            "Humans",
            "Child",
            "Child, Preschool",
            "China",
            "Respiratory Tract Infections",
            "Infant",
            "Male",
            "Female",
            "Adolescent",
            "Retrospective Studies",
            "Infant, Newborn",
            "Seasons",
            "Bacterial Infections",
            "Bacteria",
            "Hospitalization",
            "Staphylococcus aureus"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40745284/",
        "source_type": "Global"
    },
    {
        "pmid": "40744541",
        "title": "Clustering vaccine hesitancy and social media use of nurses and nursing students: a cross-sectional study.",
        "abstract": "Nurses nursing students attitude toward COVID19 Influenza vaccine crucial protecting vulnerable patient reducing vaccine hesitancy general population Social medium key spreading vaccine information opposite effect vaccine hesitancy alongside several sociodemographic professional characteristics study aim identify characteristic vaccine hesitancy among nurse nursing students multicentre crosssectional study conducted March September 2023 Data collected online survey assess I sociodemographic occupational characteristics social medium usage II vaccine hesitancy measured Vaccination Attitudes Examination Scale III social medium addiction using Bergen Social Media Addiction Scale Kmeans cluster analysis performed identify vaccine hesitancy profiles ANOVA Chisquare adopted identify key characteristic profiles Among 604 participants three profile identified Concerns unforeseen future effect relevant factor vaccine hesitancy across profile COVID19 Influenza vaccines hesitant profile included mainly older nurses Influenza vaccination uptake highest least hesitant profile also reported greater use social medium platform like YouTube LinkedIn TwitterX study provides insight develop targeted intervention appropriate nurse nursing students profiles result support tailored vaccination campaign address relevant factor vaccine hesitancy provide evidencebased information mitigate misconception enhance vaccine uptake among nurse nursing students",
        "mesh_terms": [
            "Humans",
            "Cross-Sectional Studies",
            "Social Media",
            "Students, Nursing",
            "Female",
            "Male",
            "Adult",
            "Vaccination Hesitancy",
            "COVID-19",
            "Middle Aged",
            "Influenza Vaccines",
            "Young Adult",
            "COVID-19 Vaccines",
            "Influenza, Human",
            "Vaccination",
            "Cluster Analysis",
            "Surveys and Questionnaires"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40744541/",
        "source_type": "Global"
    }
]